US20100059433A1 - Polymer deposition and modification of membranes for fouling resistance - Google Patents
Polymer deposition and modification of membranes for fouling resistance Download PDFInfo
- Publication number
- US20100059433A1 US20100059433A1 US12/500,364 US50036409A US2010059433A1 US 20100059433 A1 US20100059433 A1 US 20100059433A1 US 50036409 A US50036409 A US 50036409A US 2010059433 A1 US2010059433 A1 US 2010059433A1
- Authority
- US
- United States
- Prior art keywords
- membrane
- poly
- polydopamine
- vinyl
- dopamine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000012528 membrane Substances 0.000 title claims description 430
- 229920000642 polymer Polymers 0.000 title claims description 51
- 230000004048 modification Effects 0.000 title claims description 40
- 238000012986 modification Methods 0.000 title claims description 40
- 230000008021 deposition Effects 0.000 title description 43
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 claims abstract description 191
- 229960003638 dopamine Drugs 0.000 claims abstract description 95
- 238000000034 method Methods 0.000 claims abstract description 56
- 239000000203 mixture Substances 0.000 claims abstract description 49
- 238000000151 deposition Methods 0.000 claims abstract description 48
- 238000000576 coating method Methods 0.000 claims abstract description 46
- 239000011248 coating agent Substances 0.000 claims abstract description 40
- 230000032770 biofilm formation Effects 0.000 claims abstract description 29
- 239000000463 material Substances 0.000 claims abstract description 25
- 239000007788 liquid Substances 0.000 claims abstract description 12
- 239000002904 solvent Substances 0.000 claims abstract description 6
- -1 polyethylene Polymers 0.000 claims description 182
- 229920001690 polydopamine Polymers 0.000 claims description 143
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 92
- 230000004907 flux Effects 0.000 claims description 51
- 229920001223 polyethylene glycol Polymers 0.000 claims description 38
- 238000000746 purification Methods 0.000 claims description 28
- 229920002492 poly(sulfone) Polymers 0.000 claims description 26
- 125000003118 aryl group Chemical group 0.000 claims description 22
- 229920002647 polyamide Polymers 0.000 claims description 20
- 239000004952 Polyamide Substances 0.000 claims description 19
- 229920001155 polypropylene Polymers 0.000 claims description 15
- 229920002554 vinyl polymer Polymers 0.000 claims description 15
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 claims description 14
- 238000000926 separation method Methods 0.000 claims description 13
- 229920001577 copolymer Polymers 0.000 claims description 12
- 229920002981 polyvinylidene fluoride Polymers 0.000 claims description 12
- 150000003839 salts Chemical class 0.000 claims description 12
- 229920001477 hydrophilic polymer Polymers 0.000 claims description 11
- 239000004417 polycarbonate Substances 0.000 claims description 9
- 229920000515 polycarbonate Polymers 0.000 claims description 9
- 229920000139 polyethylene terephthalate Polymers 0.000 claims description 9
- 239000005020 polyethylene terephthalate Substances 0.000 claims description 9
- 239000004642 Polyimide Substances 0.000 claims description 8
- 125000000217 alkyl group Chemical group 0.000 claims description 8
- 229920001721 polyimide Polymers 0.000 claims description 8
- 229910052736 halogen Inorganic materials 0.000 claims description 7
- 150000002367 halogens Chemical class 0.000 claims description 7
- 230000002829 reductive effect Effects 0.000 claims description 7
- 230000015572 biosynthetic process Effects 0.000 claims description 6
- 229920003229 poly(methyl methacrylate) Polymers 0.000 claims description 6
- 229920000570 polyether Polymers 0.000 claims description 6
- 239000004698 Polyethylene Substances 0.000 claims description 5
- 229920001893 acrylonitrile styrene Polymers 0.000 claims description 5
- 239000000853 adhesive Substances 0.000 claims description 5
- 230000001070 adhesive effect Effects 0.000 claims description 5
- 150000002433 hydrophilic molecules Chemical class 0.000 claims description 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 5
- 229910021645 metal ion Inorganic materials 0.000 claims description 5
- 229920000728 polyester Polymers 0.000 claims description 5
- 229920000573 polyethylene Polymers 0.000 claims description 5
- 239000004800 polyvinyl chloride Substances 0.000 claims description 5
- SCUZVMOVTVSBLE-UHFFFAOYSA-N prop-2-enenitrile;styrene Chemical compound C=CC#N.C=CC1=CC=CC=C1 SCUZVMOVTVSBLE-UHFFFAOYSA-N 0.000 claims description 5
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 claims description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 4
- 229920000089 Cyclic olefin copolymer Polymers 0.000 claims description 4
- 239000004793 Polystyrene Substances 0.000 claims description 4
- 125000002252 acyl group Chemical group 0.000 claims description 4
- 125000003545 alkoxy group Chemical group 0.000 claims description 4
- 229910052799 carbon Inorganic materials 0.000 claims description 4
- 229920006217 cellulose acetate butyrate Polymers 0.000 claims description 4
- 230000003247 decreasing effect Effects 0.000 claims description 4
- 150000002170 ethers Chemical class 0.000 claims description 4
- 125000000524 functional group Chemical group 0.000 claims description 4
- 150000002500 ions Chemical class 0.000 claims description 4
- 229920000553 poly(phenylenevinylene) Polymers 0.000 claims description 4
- 229920002223 polystyrene Polymers 0.000 claims description 4
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 4
- 229910052709 silver Inorganic materials 0.000 claims description 4
- 239000004332 silver Substances 0.000 claims description 4
- 238000006467 substitution reaction Methods 0.000 claims description 4
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 claims description 3
- 239000004215 Carbon black (E152) Substances 0.000 claims description 3
- DQEFEBPAPFSJLV-UHFFFAOYSA-N Cellulose propionate Chemical compound CCC(=O)OCC1OC(OC(=O)CC)C(OC(=O)CC)C(OC(=O)CC)C1OC1C(OC(=O)CC)C(OC(=O)CC)C(OC(=O)CC)C(COC(=O)CC)O1 DQEFEBPAPFSJLV-UHFFFAOYSA-N 0.000 claims description 3
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 3
- 239000001856 Ethyl cellulose Substances 0.000 claims description 3
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 claims description 3
- 239000000020 Nitrocellulose Substances 0.000 claims description 3
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 claims description 3
- 229920001328 Polyvinylidene chloride Polymers 0.000 claims description 3
- 229910006069 SO3H Inorganic materials 0.000 claims description 3
- FJWGYAHXMCUOOM-QHOUIDNNSA-N [(2s,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6s)-4,5-dinitrooxy-2-(nitrooxymethyl)-6-[(2r,3r,4s,5r,6s)-4,5,6-trinitrooxy-2-(nitrooxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-3,5-dinitrooxy-6-(nitrooxymethyl)oxan-4-yl] nitrate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O)O[C@H]1[C@@H]([C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@@H](CO[N+]([O-])=O)O1)O[N+]([O-])=O)CO[N+](=O)[O-])[C@@H]1[C@@H](CO[N+]([O-])=O)O[C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O FJWGYAHXMCUOOM-QHOUIDNNSA-N 0.000 claims description 3
- 125000002947 alkylene group Chemical group 0.000 claims description 3
- 125000000732 arylene group Chemical group 0.000 claims description 3
- 239000011324 bead Substances 0.000 claims description 3
- 235000013877 carbamide Nutrition 0.000 claims description 3
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims description 3
- 229920002301 cellulose acetate Polymers 0.000 claims description 3
- 229920006218 cellulose propionate Polymers 0.000 claims description 3
- 229910052802 copper Inorganic materials 0.000 claims description 3
- 239000010949 copper Substances 0.000 claims description 3
- 229920001249 ethyl cellulose Polymers 0.000 claims description 3
- 235000019325 ethyl cellulose Nutrition 0.000 claims description 3
- 229930195733 hydrocarbon Natural products 0.000 claims description 3
- 150000002430 hydrocarbons Chemical class 0.000 claims description 3
- 229920001600 hydrophobic polymer Polymers 0.000 claims description 3
- 229920000609 methyl cellulose Polymers 0.000 claims description 3
- 239000001923 methylcellulose Substances 0.000 claims description 3
- 235000010981 methylcellulose Nutrition 0.000 claims description 3
- 125000000896 monocarboxylic acid group Chemical group 0.000 claims description 3
- 239000002105 nanoparticle Substances 0.000 claims description 3
- 229920001220 nitrocellulos Polymers 0.000 claims description 3
- 239000003973 paint Substances 0.000 claims description 3
- 229920006156 poly(arylene oxide) Polymers 0.000 claims description 3
- 229920002627 poly(phosphazenes) Polymers 0.000 claims description 3
- 229920002037 poly(vinyl butyral) polymer Polymers 0.000 claims description 3
- 229920001230 polyarylate Polymers 0.000 claims description 3
- 229920002480 polybenzimidazole Polymers 0.000 claims description 3
- 229920000306 polymethylpentene Polymers 0.000 claims description 3
- 229920006380 polyphenylene oxide Polymers 0.000 claims description 3
- 239000005077 polysulfide Substances 0.000 claims description 3
- 229920001021 polysulfide Polymers 0.000 claims description 3
- 150000008117 polysulfides Polymers 0.000 claims description 3
- 229920002635 polyurethane Polymers 0.000 claims description 3
- 239000004814 polyurethane Substances 0.000 claims description 3
- 239000011118 polyvinyl acetate Substances 0.000 claims description 3
- 229920002689 polyvinyl acetate Polymers 0.000 claims description 3
- 229920000915 polyvinyl chloride Polymers 0.000 claims description 3
- 229920002620 polyvinyl fluoride Polymers 0.000 claims description 3
- 229920006395 saturated elastomer Polymers 0.000 claims description 3
- 150000004756 silanes Chemical class 0.000 claims description 3
- 229920003048 styrene butadiene rubber Polymers 0.000 claims description 3
- 125000000020 sulfo group Chemical group O=S(=O)([*])O[H] 0.000 claims description 3
- 150000003568 thioethers Chemical class 0.000 claims description 3
- 229920001567 vinyl ester resin Polymers 0.000 claims description 3
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 claims description 3
- 239000008096 xylene Substances 0.000 claims description 3
- 239000004713 Cyclic olefin copolymer Substances 0.000 claims description 2
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 claims description 2
- 239000005977 Ethylene Substances 0.000 claims description 2
- 239000004696 Poly ether ether ketone Substances 0.000 claims description 2
- 239000004697 Polyetherimide Substances 0.000 claims description 2
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 2
- 239000000956 alloy Substances 0.000 claims description 2
- 229910045601 alloy Inorganic materials 0.000 claims description 2
- 239000003822 epoxy resin Substances 0.000 claims description 2
- LNEPOXFFQSENCJ-UHFFFAOYSA-N haloperidol Chemical compound C1CC(O)(C=2C=CC(Cl)=CC=2)CCN1CCCC(=O)C1=CC=C(F)C=C1 LNEPOXFFQSENCJ-UHFFFAOYSA-N 0.000 claims description 2
- 239000002082 metal nanoparticle Substances 0.000 claims description 2
- 229920003227 poly(N-vinyl carbazole) Polymers 0.000 claims description 2
- 229920000647 polyepoxide Polymers 0.000 claims description 2
- 229920002530 polyetherether ketone Polymers 0.000 claims description 2
- 229920001601 polyetherimide Polymers 0.000 claims description 2
- 235000000346 sugar Nutrition 0.000 claims description 2
- 150000008163 sugars Chemical class 0.000 claims description 2
- 229910052725 zinc Inorganic materials 0.000 claims description 2
- 239000011701 zinc Substances 0.000 claims description 2
- 239000002202 Polyethylene glycol Substances 0.000 claims 1
- 229920000058 polyacrylate Polymers 0.000 claims 1
- 230000009467 reduction Effects 0.000 abstract description 4
- 230000002265 prevention Effects 0.000 abstract description 2
- 230000008030 elimination Effects 0.000 abstract 1
- 238000003379 elimination reaction Methods 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 51
- 238000000108 ultra-filtration Methods 0.000 description 43
- 210000004027 cell Anatomy 0.000 description 38
- 238000001471 micro-filtration Methods 0.000 description 36
- 238000001223 reverse osmosis Methods 0.000 description 33
- 239000010410 layer Substances 0.000 description 26
- 238000001728 nano-filtration Methods 0.000 description 25
- 239000000178 monomer Substances 0.000 description 16
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 14
- 229940098773 bovine serum albumin Drugs 0.000 description 14
- DIOQZVSQGTUSAI-UHFFFAOYSA-N decane Chemical compound CCCCCCCCCC DIOQZVSQGTUSAI-UHFFFAOYSA-N 0.000 description 14
- 238000007654 immersion Methods 0.000 description 14
- 239000003921 oil Substances 0.000 description 14
- 235000019198 oils Nutrition 0.000 description 14
- 239000011148 porous material Substances 0.000 description 14
- 241000894006 Bacteria Species 0.000 description 13
- 239000000839 emulsion Substances 0.000 description 13
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 13
- 239000004743 Polypropylene Substances 0.000 description 12
- 238000002474 experimental method Methods 0.000 description 12
- 238000001914 filtration Methods 0.000 description 11
- 239000012466 permeate Substances 0.000 description 11
- 239000000758 substrate Substances 0.000 description 11
- 229910021642 ultra pure water Inorganic materials 0.000 description 11
- 239000012498 ultrapure water Substances 0.000 description 11
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 10
- 239000013612 plasmid Substances 0.000 description 10
- 239000011247 coating layer Substances 0.000 description 9
- 238000004020 luminiscence type Methods 0.000 description 9
- 244000005700 microbiome Species 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- 238000011282 treatment Methods 0.000 description 9
- PVVTWNMXEHROIA-UHFFFAOYSA-N 2-(3-hydroxypropyl)-1h-quinazolin-4-one Chemical compound C1=CC=C2NC(CCCO)=NC(=O)C2=C1 PVVTWNMXEHROIA-UHFFFAOYSA-N 0.000 description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 239000004810 polytetrafluoroethylene Substances 0.000 description 8
- 230000010069 protein adhesion Effects 0.000 description 8
- DZGWFCGJZKJUFP-UHFFFAOYSA-N tyramine Chemical compound NCCC1=CC=C(O)C=C1 DZGWFCGJZKJUFP-UHFFFAOYSA-N 0.000 description 8
- 230000001580 bacterial effect Effects 0.000 description 7
- FPPNZSSZRUTDAP-UWFZAAFLSA-N carbenicillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)C(C(O)=O)C1=CC=CC=C1 FPPNZSSZRUTDAP-UWFZAAFLSA-N 0.000 description 7
- 229960003669 carbenicillin Drugs 0.000 description 7
- 239000003795 chemical substances by application Substances 0.000 description 7
- 230000007423 decrease Effects 0.000 description 7
- XJWSAJYUBXQQDR-UHFFFAOYSA-M dodecyltrimethylammonium bromide Chemical compound [Br-].CCCCCCCCCCCC[N+](C)(C)C XJWSAJYUBXQQDR-UHFFFAOYSA-M 0.000 description 7
- 239000010408 film Substances 0.000 description 7
- 238000005259 measurement Methods 0.000 description 7
- 239000002245 particle Substances 0.000 description 7
- 125000003396 thiol group Chemical group [H]S* 0.000 description 7
- 239000000654 additive Substances 0.000 description 6
- 230000000996 additive effect Effects 0.000 description 6
- 150000001412 amines Chemical group 0.000 description 6
- 125000003277 amino group Chemical group 0.000 description 6
- 230000008901 benefit Effects 0.000 description 6
- 230000003115 biocidal effect Effects 0.000 description 6
- 230000012010 growth Effects 0.000 description 6
- 230000002209 hydrophobic effect Effects 0.000 description 6
- 230000002427 irreversible effect Effects 0.000 description 6
- RHCSKNNOAZULRK-UHFFFAOYSA-N mescaline Chemical compound COC1=CC(CCN)=CC(OC)=C1OC RHCSKNNOAZULRK-UHFFFAOYSA-N 0.000 description 6
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 6
- BQCIDUSAKPWEOX-UHFFFAOYSA-N 1,1-Difluoroethene Chemical compound FC(F)=C BQCIDUSAKPWEOX-UHFFFAOYSA-N 0.000 description 5
- 230000003373 anti-fouling effect Effects 0.000 description 5
- 230000010065 bacterial adhesion Effects 0.000 description 5
- 125000005843 halogen group Chemical group 0.000 description 5
- 238000009285 membrane fouling Methods 0.000 description 5
- 239000004926 polymethyl methacrylate Substances 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 230000000717 retained effect Effects 0.000 description 5
- 239000000523 sample Substances 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 238000012546 transfer Methods 0.000 description 5
- ANOUKFYBOAKOIR-UHFFFAOYSA-N 3,4-dimethoxyphenylethylamine Chemical compound COC1=CC=C(CCN)C=C1OC ANOUKFYBOAKOIR-UHFFFAOYSA-N 0.000 description 4
- LTPVSOCPYWDIFU-UHFFFAOYSA-N 4-methoxyphenylethylamine Chemical compound COC1=CC=C(CCN)C=C1 LTPVSOCPYWDIFU-UHFFFAOYSA-N 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- BHHGXPLMPWCGHP-UHFFFAOYSA-N Phenethylamine Chemical compound NCCC1=CC=CC=C1 BHHGXPLMPWCGHP-UHFFFAOYSA-N 0.000 description 4
- 206010052428 Wound Diseases 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 125000003342 alkenyl group Chemical group 0.000 description 4
- 125000002877 alkyl aryl group Chemical group 0.000 description 4
- 238000003556 assay Methods 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 125000001188 haloalkyl group Chemical group 0.000 description 4
- GHFGJTVYMNRGBY-UHFFFAOYSA-N m-tyramine Chemical compound NCCC1=CC=CC(O)=C1 GHFGJTVYMNRGBY-UHFFFAOYSA-N 0.000 description 4
- 238000006116 polymerization reaction Methods 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- WGTASENVNYJZBK-UHFFFAOYSA-N 3,4,5-trimethoxyamphetamine Chemical compound COC1=CC(CC(C)N)=CC(OC)=C1OC WGTASENVNYJZBK-UHFFFAOYSA-N 0.000 description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 3
- 239000006137 Luria-Bertani broth Substances 0.000 description 3
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000000845 anti-microbial effect Effects 0.000 description 3
- AMEDKBHURXXSQO-UHFFFAOYSA-N azonous acid Chemical compound ONO AMEDKBHURXXSQO-UHFFFAOYSA-N 0.000 description 3
- 238000005137 deposition process Methods 0.000 description 3
- 229920001971 elastomer Polymers 0.000 description 3
- 239000012510 hollow fiber Substances 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 239000011859 microparticle Substances 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 239000005416 organic matter Substances 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- LFGREXWGYUGZLY-UHFFFAOYSA-N phosphoryl Chemical group [P]=O LFGREXWGYUGZLY-UHFFFAOYSA-N 0.000 description 3
- 229920006393 polyether sulfone Polymers 0.000 description 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 3
- 230000035755 proliferation Effects 0.000 description 3
- 125000001424 substituent group Chemical group 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- 235000015112 vegetable and seed oil Nutrition 0.000 description 3
- 239000008158 vegetable oil Substances 0.000 description 3
- DBGIVFWFUFKIQN-UHFFFAOYSA-N (+-)-Fenfluramine Chemical compound CCNC(C)CC1=CC=CC(C(F)(F)F)=C1 DBGIVFWFUFKIQN-UHFFFAOYSA-N 0.000 description 2
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 2
- NTJQREUGJKIARY-UHFFFAOYSA-N 1-(2,5-dimethoxy-4-methylphenyl)propan-2-amine Chemical compound COC1=CC(CC(C)N)=C(OC)C=C1C NTJQREUGJKIARY-UHFFFAOYSA-N 0.000 description 2
- KXKYMEWDPWQCQT-UHFFFAOYSA-N 1-[3-(2-aminoethyl)phenyl]ethanone Chemical compound CC(=O)C1=CC=CC(CCN)=C1 KXKYMEWDPWQCQT-UHFFFAOYSA-N 0.000 description 2
- GHEAOCPXAWGVSO-UHFFFAOYSA-N 1-[4-(2-aminoethyl)phenyl]ethanone Chemical compound CC(=O)C1=CC=C(CCN)C=C1 GHEAOCPXAWGVSO-UHFFFAOYSA-N 0.000 description 2
- FCEHBMOGCRZNNI-UHFFFAOYSA-N 1-benzothiophene Chemical compound C1=CC=C2SC=CC2=C1 FCEHBMOGCRZNNI-UHFFFAOYSA-N 0.000 description 2
- FXMWUTGUCAKGQL-UHFFFAOYSA-N 2,5-dimethoxy-4-bromoamphetamine Chemical compound COC1=CC(CC(C)N)=C(OC)C=C1Br FXMWUTGUCAKGQL-UHFFFAOYSA-N 0.000 description 2
- YMHOBZXQZVXHBM-UHFFFAOYSA-N 2,5-dimethoxy-4-bromophenethylamine Chemical compound COC1=CC(CCN)=C(OC)C=C1Br YMHOBZXQZVXHBM-UHFFFAOYSA-N 0.000 description 2
- CGUNKAXAEZSOFA-UHFFFAOYSA-N 2-(2,4,6-trimethoxyphenyl)ethanamine Chemical compound COC1=CC(OC)=C(CCN)C(OC)=C1 CGUNKAXAEZSOFA-UHFFFAOYSA-N 0.000 description 2
- QUIIKTQSGAWIAC-UHFFFAOYSA-N 2-(2,4,6-trimethylphenyl)ethanamine Chemical compound CC1=CC(C)=C(CCN)C(C)=C1 QUIIKTQSGAWIAC-UHFFFAOYSA-N 0.000 description 2
- YDTQAPOROITHCN-UHFFFAOYSA-N 2-(2,4-dimethoxyphenyl)ethanamine Chemical compound COC1=CC=C(CCN)C(OC)=C1 YDTQAPOROITHCN-UHFFFAOYSA-N 0.000 description 2
- VQGZTRKXOUWMAC-UHFFFAOYSA-N 2-(2,4-dimethylphenyl)ethanamine Chemical compound CC1=CC=C(CCN)C(C)=C1 VQGZTRKXOUWMAC-UHFFFAOYSA-N 0.000 description 2
- OEWYVHJLQDINFS-UHFFFAOYSA-N 2-(2-aminoethyl)aniline Chemical compound NCCC1=CC=CC=C1N OEWYVHJLQDINFS-UHFFFAOYSA-N 0.000 description 2
- VDSGSZWDSYFYCJ-UHFFFAOYSA-N 2-(2-ethoxyphenyl)ethanamine Chemical compound CCOC1=CC=CC=C1CCN VDSGSZWDSYFYCJ-UHFFFAOYSA-N 0.000 description 2
- WSWPCNMLEVZGSM-UHFFFAOYSA-N 2-(2-methoxyphenyl)ethanamine Chemical compound COC1=CC=CC=C1CCN WSWPCNMLEVZGSM-UHFFFAOYSA-N 0.000 description 2
- UKHBJYFFALMACQ-UHFFFAOYSA-N 2-(3-benzylphenyl)ethanamine Chemical compound NCCC1=CC=CC(CC=2C=CC=CC=2)=C1 UKHBJYFFALMACQ-UHFFFAOYSA-N 0.000 description 2
- PBWUNLYMHNSAPQ-UHFFFAOYSA-N 2-(3-ethoxyphenyl)ethanamine Chemical compound CCOC1=CC=CC(CCN)=C1 PBWUNLYMHNSAPQ-UHFFFAOYSA-N 0.000 description 2
- PXADRXFYOVHBED-UHFFFAOYSA-N 2-(3-ethylphenyl)ethanamine Chemical compound CCC1=CC=CC(CCN)=C1 PXADRXFYOVHBED-UHFFFAOYSA-N 0.000 description 2
- WJBMRZAHTUFBGE-UHFFFAOYSA-N 2-(3-methoxyphenyl)ethanamine Chemical compound COC1=CC=CC(CCN)=C1 WJBMRZAHTUFBGE-UHFFFAOYSA-N 0.000 description 2
- STZMTXBXSFWOBA-UHFFFAOYSA-N 2-(3-phenylmethoxyphenyl)ethanamine Chemical compound NCCC1=CC=CC(OCC=2C=CC=CC=2)=C1 STZMTXBXSFWOBA-UHFFFAOYSA-N 0.000 description 2
- CDJFWESZVLIVIS-UHFFFAOYSA-N 2-(3-propoxyphenyl)ethanamine Chemical compound CCCOC1=CC=CC(CCN)=C1 CDJFWESZVLIVIS-UHFFFAOYSA-N 0.000 description 2
- OIOGOZZYBQRPLA-UHFFFAOYSA-N 2-(4-butoxyphenyl)ethanamine Chemical compound CCCCOC1=CC=C(CCN)C=C1 OIOGOZZYBQRPLA-UHFFFAOYSA-N 0.000 description 2
- OQIMYLCOTAZDEZ-UHFFFAOYSA-N 2-(4-ethoxyphenyl)ethanamine Chemical compound CCOC1=CC=C(CCN)C=C1 OQIMYLCOTAZDEZ-UHFFFAOYSA-N 0.000 description 2
- XLJAVPNHXCHBPU-UHFFFAOYSA-N 2-(4-ethylphenyl)ethanamine Chemical compound CCC1=CC=C(CCN)C=C1 XLJAVPNHXCHBPU-UHFFFAOYSA-N 0.000 description 2
- GPEIEKRQHRLDTB-UHFFFAOYSA-N 2-(4-hexylphenyl)ethanamine Chemical compound CCCCCCC1=CC=C(CCN)C=C1 GPEIEKRQHRLDTB-UHFFFAOYSA-N 0.000 description 2
- JNHPLGDXCJAUBX-UHFFFAOYSA-N 2-(4-phenoxyphenyl)ethanamine Chemical compound C1=CC(CCN)=CC=C1OC1=CC=CC=C1 JNHPLGDXCJAUBX-UHFFFAOYSA-N 0.000 description 2
- WHPLBPSDTIZFSX-UHFFFAOYSA-N 2-(4-phenylphenyl)ethanamine Chemical compound C1=CC(CCN)=CC=C1C1=CC=CC=C1 WHPLBPSDTIZFSX-UHFFFAOYSA-N 0.000 description 2
- APCYRCMSBGOFCL-UHFFFAOYSA-N 2-[3-(2,4,6-trimethylphenyl)phenyl]ethanamine Chemical compound CC1=CC(C)=CC(C)=C1C1=CC=CC(CCN)=C1 APCYRCMSBGOFCL-UHFFFAOYSA-N 0.000 description 2
- WZNMUUHHCQAAPO-UHFFFAOYSA-N 2-[3-(2-methoxyethyl)phenyl]ethanamine Chemical compound COCCC1=CC=CC(CCN)=C1 WZNMUUHHCQAAPO-UHFFFAOYSA-N 0.000 description 2
- NRBZSHQHSAEUHT-UHFFFAOYSA-N 2-[3-(methoxymethyl)phenyl]ethanamine Chemical compound COCC1=CC=CC(CCN)=C1 NRBZSHQHSAEUHT-UHFFFAOYSA-N 0.000 description 2
- QBPQHSPIVXPXKQ-UHFFFAOYSA-N 2-[4-(2-aminoethyl)phenoxy]ethanol Chemical compound NCCC1=CC=C(OCCO)C=C1 QBPQHSPIVXPXKQ-UHFFFAOYSA-N 0.000 description 2
- RQQNQMFYCJLHCD-UHFFFAOYSA-N 2-[4-(2-aminoethyl)phenyl]aniline Chemical compound C1=CC(CCN)=CC=C1C1=CC=CC=C1N RQQNQMFYCJLHCD-UHFFFAOYSA-N 0.000 description 2
- SWESRARCMPPTGM-UHFFFAOYSA-N 2-[4-(2-aminoethyl)phenyl]ethanol Chemical compound NCCC1=CC=C(CCO)C=C1 SWESRARCMPPTGM-UHFFFAOYSA-N 0.000 description 2
- NHRXAVTVKAFCCI-UHFFFAOYSA-N 2-[4-(2-chlorophenyl)phenyl]ethanamine Chemical compound C1=CC(CCN)=CC=C1C1=CC=CC=C1Cl NHRXAVTVKAFCCI-UHFFFAOYSA-N 0.000 description 2
- AMTGWWXPYZJITK-UHFFFAOYSA-N 2-[4-(2-methoxyethyl)phenyl]ethanamine Chemical compound COCCC1=CC=C(CCN)C=C1 AMTGWWXPYZJITK-UHFFFAOYSA-N 0.000 description 2
- SLVNOGNJOUXCSM-UHFFFAOYSA-N 2-[4-(2-phenoxyethyl)phenyl]ethanamine Chemical compound C1=CC(CCN)=CC=C1CCOC1=CC=CC=C1 SLVNOGNJOUXCSM-UHFFFAOYSA-N 0.000 description 2
- BKRAIFUYJHWSEW-UHFFFAOYSA-N 2-[4-(2-phenylethyl)phenyl]ethanamine Chemical compound C1=CC(CCN)=CC=C1CCC1=CC=CC=C1 BKRAIFUYJHWSEW-UHFFFAOYSA-N 0.000 description 2
- PTIWXRIQUSOROO-UHFFFAOYSA-N 2-[4-(3-chlorophenoxy)phenyl]ethanamine Chemical compound C1=CC(CCN)=CC=C1OC1=CC=CC(Cl)=C1 PTIWXRIQUSOROO-UHFFFAOYSA-N 0.000 description 2
- KTDXXMJLLJJABP-UHFFFAOYSA-N 2-[4-(methoxymethyl)phenyl]ethanamine Chemical compound COCC1=CC=C(CCN)C=C1 KTDXXMJLLJJABP-UHFFFAOYSA-N 0.000 description 2
- GPKNHRSSJDAUGA-UHFFFAOYSA-N 2-[4-[(2-methylpropan-2-yl)oxy]phenyl]ethanamine Chemical compound CC(C)(C)OC1=CC=C(CCN)C=C1 GPKNHRSSJDAUGA-UHFFFAOYSA-N 0.000 description 2
- OWOUKRYOZIZVFK-UHFFFAOYSA-N 2-methylphenethylamine Chemical compound CC1=CC=CC=C1CCN OWOUKRYOZIZVFK-UHFFFAOYSA-N 0.000 description 2
- CGKQFIWIPSIVAS-UHFFFAOYSA-N 2c-c Chemical compound COC1=CC(CCN)=C(OC)C=C1Cl CGKQFIWIPSIVAS-UHFFFAOYSA-N 0.000 description 2
- UNQQFDCVEMVQHM-UHFFFAOYSA-N 2c-d Chemical compound COC1=CC(CCN)=C(OC)C=C1C UNQQFDCVEMVQHM-UHFFFAOYSA-N 0.000 description 2
- VDRGNAMREYBIHA-UHFFFAOYSA-N 2c-e Chemical compound CCC1=CC(OC)=C(CCN)C=C1OC VDRGNAMREYBIHA-UHFFFAOYSA-N 0.000 description 2
- PQHQBRJAAZQXHL-UHFFFAOYSA-N 2c-i Chemical compound COC1=CC(CCN)=C(OC)C=C1I PQHQBRJAAZQXHL-UHFFFAOYSA-N 0.000 description 2
- ZMUSDZGRRJGRAO-UHFFFAOYSA-N 2c-n Chemical compound COC1=CC([N+]([O-])=O)=C(OC)C=C1CCN ZMUSDZGRRJGRAO-UHFFFAOYSA-N 0.000 description 2
- HCWQGDLBIKOJPM-UHFFFAOYSA-N 2c-t-2 Chemical compound CCSC1=CC(OC)=C(CCN)C=C1OC HCWQGDLBIKOJPM-UHFFFAOYSA-N 0.000 description 2
- ZBUUUKBTOCTOPW-UHFFFAOYSA-N 2c-t-21 Chemical compound COC1=CC(SCCF)=C(OC)C=C1CCN ZBUUUKBTOCTOPW-UHFFFAOYSA-N 0.000 description 2
- HDYZSVKZKDPLDT-UHFFFAOYSA-N 2c-t-4 Chemical compound COC1=CC(SC(C)C)=C(OC)C=C1CCN HDYZSVKZKDPLDT-UHFFFAOYSA-N 0.000 description 2
- OLEVEPDJOFPJTF-UHFFFAOYSA-N 2c-t-7 Chemical compound CCCSC1=CC(OC)=C(CCN)C=C1OC OLEVEPDJOFPJTF-UHFFFAOYSA-N 0.000 description 2
- AHMSSHCYIDBVQB-UHFFFAOYSA-N 2c-t-8 Chemical compound C1=C(CCN)C(OC)=CC(SCC2CC2)=C1OC AHMSSHCYIDBVQB-UHFFFAOYSA-N 0.000 description 2
- SHXWCVYOXRDMCX-UHFFFAOYSA-N 3,4-methylenedioxymethamphetamine Chemical compound CNC(C)CC1=CC=C2OCOC2=C1 SHXWCVYOXRDMCX-UHFFFAOYSA-N 0.000 description 2
- CJVSFUCZDMBRRY-UHFFFAOYSA-N 3-[4-(2-aminoethyl)phenyl]propan-1-ol Chemical compound NCCC1=CC=C(CCCO)C=C1 CJVSFUCZDMBRRY-UHFFFAOYSA-N 0.000 description 2
- GUERDLPJJJMIEU-UHFFFAOYSA-N 3-methylphenethylamine Chemical compound CC1=CC=CC(CCN)=C1 GUERDLPJJJMIEU-UHFFFAOYSA-N 0.000 description 2
- WEPKDBHGQDETGY-UHFFFAOYSA-N 3-nitrophenylethylamine Chemical compound NCCC1=CC=CC([N+]([O-])=O)=C1 WEPKDBHGQDETGY-UHFFFAOYSA-N 0.000 description 2
- LNPMZQXEPNWCMG-UHFFFAOYSA-N 4-(2-aminoethyl)aniline Chemical compound NCCC1=CC=C(N)C=C1 LNPMZQXEPNWCMG-UHFFFAOYSA-N 0.000 description 2
- AVKJTBFHXAKKER-UHFFFAOYSA-N 4-(2-aminoethyl)benzene-1,3-diamine Chemical compound NCCC1=CC=C(N)C=C1N AVKJTBFHXAKKER-UHFFFAOYSA-N 0.000 description 2
- QAVFEDRVOUKIPM-UHFFFAOYSA-N 4-Fluoro-2,5-dimethoxyphenethylamine Chemical compound COC1=CC(CCN)=C(OC)C=C1F QAVFEDRVOUKIPM-UHFFFAOYSA-N 0.000 description 2
- LJJZAHLEBAXGQJ-UHFFFAOYSA-N 4-[4-(2-aminoethyl)phenoxy]aniline Chemical compound C1=CC(CCN)=CC=C1OC1=CC=C(N)C=C1 LJJZAHLEBAXGQJ-UHFFFAOYSA-N 0.000 description 2
- VKJXAQYPOTYDLO-UHFFFAOYSA-N 4-methylphenethylamine Chemical compound CC1=CC=C(CCN)C=C1 VKJXAQYPOTYDLO-UHFFFAOYSA-N 0.000 description 2
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 2
- SOGAXMICEFXMKE-UHFFFAOYSA-N Butylmethacrylate Chemical compound CCCCOC(=O)C(C)=C SOGAXMICEFXMKE-UHFFFAOYSA-N 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical compound COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 description 2
- 241000237536 Mytilus edulis Species 0.000 description 2
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- 239000004676 acrylonitrile butadiene styrene Substances 0.000 description 2
- 230000001464 adherent effect Effects 0.000 description 2
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 2
- 230000004075 alteration Effects 0.000 description 2
- 230000003214 anti-biofilm Effects 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 125000004429 atom Chemical group 0.000 description 2
- IOJUPLGTWVMSFF-UHFFFAOYSA-N benzothiazole Chemical compound C1=CC=C2SC=NC2=C1 IOJUPLGTWVMSFF-UHFFFAOYSA-N 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 238000005266 casting Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 229920000891 common polymer Polymers 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 230000003750 conditioning effect Effects 0.000 description 2
- 239000000356 contaminant Substances 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 230000032798 delamination Effects 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 238000000572 ellipsometry Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000001125 extrusion Methods 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 2
- 150000002241 furanones Chemical class 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 150000004820 halides Chemical class 0.000 description 2
- 238000007731 hot pressing Methods 0.000 description 2
- 244000052637 human pathogen Species 0.000 description 2
- 238000001746 injection moulding Methods 0.000 description 2
- AWJUIBRHMBBTKR-UHFFFAOYSA-N isoquinoline Chemical compound C1=NC=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-N 0.000 description 2
- 238000010030 laminating Methods 0.000 description 2
- 238000009630 liquid culture Methods 0.000 description 2
- 239000013528 metallic particle Substances 0.000 description 2
- 238000001465 metallisation Methods 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- RRIRDPSOCUCGBV-UHFFFAOYSA-N methylenedioxyphenethylamine Chemical compound NCCC1=CC=C2OCOC2=C1 RRIRDPSOCUCGBV-UHFFFAOYSA-N 0.000 description 2
- 235000020638 mussel Nutrition 0.000 description 2
- 229960002748 norepinephrine Drugs 0.000 description 2
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- DIVDFFZHCJEHGG-UHFFFAOYSA-N oxidopamine Chemical compound NCCC1=CC(O)=C(O)C=C1O DIVDFFZHCJEHGG-UHFFFAOYSA-N 0.000 description 2
- 238000010422 painting Methods 0.000 description 2
- 230000002572 peristaltic effect Effects 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 229940117803 phenethylamine Drugs 0.000 description 2
- 229920000867 polyelectrolyte Polymers 0.000 description 2
- 239000004626 polylactic acid Substances 0.000 description 2
- 229920005597 polymer membrane Polymers 0.000 description 2
- 239000005033 polyvinylidene chloride Substances 0.000 description 2
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 2
- 238000000807 solvent casting Methods 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 230000003068 static effect Effects 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 239000010409 thin film Substances 0.000 description 2
- UZRJWRFLYPENFH-UHFFFAOYSA-N trimethyl-[4-(2-phenylethynyl)phenyl]silane Chemical group C1=CC([Si](C)(C)C)=CC=C1C#CC1=CC=CC=C1 UZRJWRFLYPENFH-UHFFFAOYSA-N 0.000 description 2
- 238000004065 wastewater treatment Methods 0.000 description 2
- 239000002569 water oil cream Substances 0.000 description 2
- PSGCQDPCAWOCSH-UHFFFAOYSA-N (4,7,7-trimethyl-3-bicyclo[2.2.1]heptanyl) prop-2-enoate Chemical compound C1CC2(C)C(OC(=O)C=C)CC1C2(C)C PSGCQDPCAWOCSH-UHFFFAOYSA-N 0.000 description 1
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 1
- 229930182837 (R)-adrenaline Natural products 0.000 description 1
- KTZQTRPPVKQPFO-UHFFFAOYSA-N 1,2-benzoxazole Chemical compound C1=CC=C2C=NOC2=C1 KTZQTRPPVKQPFO-UHFFFAOYSA-N 0.000 description 1
- HIACAHMKXQESOV-UHFFFAOYSA-N 1,2-bis(prop-1-en-2-yl)benzene Chemical compound CC(=C)C1=CC=CC=C1C(C)=C HIACAHMKXQESOV-UHFFFAOYSA-N 0.000 description 1
- BCMCBBGGLRIHSE-UHFFFAOYSA-N 1,3-benzoxazole Chemical compound C1=CC=C2OC=NC2=C1 BCMCBBGGLRIHSE-UHFFFAOYSA-N 0.000 description 1
- NNHZDYGQPLBFGN-UHFFFAOYSA-N 1-[3-(2-aminopropyl)phenyl]ethanone Chemical compound CC(N)CC1=CC=CC(C(C)=O)=C1 NNHZDYGQPLBFGN-UHFFFAOYSA-N 0.000 description 1
- HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical compound C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 description 1
- BAXOFTOLAUCFNW-UHFFFAOYSA-N 1H-indazole Chemical compound C1=CC=C2C=NNC2=C1 BAXOFTOLAUCFNW-UHFFFAOYSA-N 0.000 description 1
- WNCUVUUEJZEATP-UHFFFAOYSA-N 2,5-Dimethoxy-phenethylamine Chemical compound COC1=CC=C(OC)C(CCN)=C1 WNCUVUUEJZEATP-UHFFFAOYSA-N 0.000 description 1
- JQJRESSXOVAECC-UHFFFAOYSA-N 2,5-dimethoxy-4-nitroamphetamine Chemical compound COC1=CC(N(=O)=O)=C(OC)C=C1CC(C)N JQJRESSXOVAECC-UHFFFAOYSA-N 0.000 description 1
- XKBUFTXNLBWTFP-UHFFFAOYSA-N 2-(2,3-dimethoxyphenyl)ethanamine Chemical compound COC1=CC=CC(CCN)=C1OC XKBUFTXNLBWTFP-UHFFFAOYSA-N 0.000 description 1
- VHJKDOLGYMULOP-UHFFFAOYSA-N 2-(2,4-dichlorophenyl)ethanamine Chemical compound NCCC1=CC=C(Cl)C=C1Cl VHJKDOLGYMULOP-UHFFFAOYSA-N 0.000 description 1
- XYMGUIWNLBMCIF-UHFFFAOYSA-N 2-(2-aminoethyl)benzene-1,4-diol Chemical compound NCCC1=CC(O)=CC=C1O XYMGUIWNLBMCIF-UHFFFAOYSA-N 0.000 description 1
- RZBOMSOHMOVUES-UHFFFAOYSA-N 2-(2-chlorophenyl)ethanamine Chemical compound NCCC1=CC=CC=C1Cl RZBOMSOHMOVUES-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- ZHSFEDDRTVLPHH-UHFFFAOYSA-N 2-(3,5-dimethoxyphenyl)ethanamine Chemical compound COC1=CC(CCN)=CC(OC)=C1 ZHSFEDDRTVLPHH-UHFFFAOYSA-N 0.000 description 1
- ORHRHMLEFQBHND-UHFFFAOYSA-N 2-(3-bromophenyl)ethanamine Chemical compound NCCC1=CC=CC(Br)=C1 ORHRHMLEFQBHND-UHFFFAOYSA-N 0.000 description 1
- NRHVNPYOTNGECT-UHFFFAOYSA-N 2-(3-chlorophenyl)ethanamine Chemical compound NCCC1=CC=CC(Cl)=C1 NRHVNPYOTNGECT-UHFFFAOYSA-N 0.000 description 1
- SRXFXCKTIGELTI-UHFFFAOYSA-N 2-(4-chlorophenyl)ethanamine Chemical compound NCCC1=CC=C(Cl)C=C1 SRXFXCKTIGELTI-UHFFFAOYSA-N 0.000 description 1
- CKLFJWXRWIQYOC-UHFFFAOYSA-N 2-(4-fluorophenyl)ethanamine Chemical compound NCCC1=CC=C(F)C=C1 CKLFJWXRWIQYOC-UHFFFAOYSA-N 0.000 description 1
- BGMZUEKZENQUJY-UHFFFAOYSA-N 2-(4-iodo-2,5-dimethoxyphenyl)-1-methylethylamine Chemical compound COC1=CC(CC(C)N)=C(OC)C=C1I BGMZUEKZENQUJY-UHFFFAOYSA-N 0.000 description 1
- IQFHGSFDGGJWSJ-UHFFFAOYSA-N 2-(4-iodophenyl)ethanamine Chemical compound NCCC1=CC=C(I)C=C1 IQFHGSFDGGJWSJ-UHFFFAOYSA-N 0.000 description 1
- AXEJSBWWIHAWJM-UHFFFAOYSA-N 2-(4-methoxy-1,3-benzodioxol-5-yl)ethanamine Chemical compound C1=C(CCN)C(OC)=C2OCOC2=C1 AXEJSBWWIHAWJM-UHFFFAOYSA-N 0.000 description 1
- VHBCQDKBQRHHPZ-UHFFFAOYSA-N 2-(6-methoxy-1,3-benzodioxol-5-yl)ethanamine Chemical compound C1=C(CCN)C(OC)=CC2=C1OCO2 VHBCQDKBQRHHPZ-UHFFFAOYSA-N 0.000 description 1
- QHVBLSNVXDSMEB-UHFFFAOYSA-N 2-(diethylamino)ethyl prop-2-enoate Chemical compound CCN(CC)CCOC(=O)C=C QHVBLSNVXDSMEB-UHFFFAOYSA-N 0.000 description 1
- GOXQRTZXKQZDDN-UHFFFAOYSA-N 2-Ethylhexyl acrylate Chemical compound CCCCC(CC)COC(=O)C=C GOXQRTZXKQZDDN-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- VETIYACESIPJSO-UHFFFAOYSA-N 2-[2-(2-hydroxyethoxy)ethoxy]ethyl prop-2-enoate Chemical compound OCCOCCOCCOC(=O)C=C VETIYACESIPJSO-UHFFFAOYSA-N 0.000 description 1
- BPVYCXMGJPKOTQ-UHFFFAOYSA-N 2-[3-(trifluoromethyl)phenyl]ethanamine Chemical compound NCCC1=CC=CC(C(F)(F)F)=C1 BPVYCXMGJPKOTQ-UHFFFAOYSA-N 0.000 description 1
- UXGVMFHEKMGWMA-UHFFFAOYSA-N 2-benzofuran Chemical compound C1=CC=CC2=COC=C21 UXGVMFHEKMGWMA-UHFFFAOYSA-N 0.000 description 1
- LYTMVABTDYMBQK-UHFFFAOYSA-N 2-benzothiophene Chemical compound C1=CC=CC2=CSC=C21 LYTMVABTDYMBQK-UHFFFAOYSA-N 0.000 description 1
- PNLQPWWBHXMFCA-UHFFFAOYSA-N 2-chloroprop-1-ene Chemical compound CC(Cl)=C PNLQPWWBHXMFCA-UHFFFAOYSA-N 0.000 description 1
- VMSBGXAJJLPWKV-UHFFFAOYSA-N 2-ethenylbenzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1C=C VMSBGXAJJLPWKV-UHFFFAOYSA-N 0.000 description 1
- XUDBVJCTLZTSDC-UHFFFAOYSA-N 2-ethenylbenzoic acid Chemical compound OC(=O)C1=CC=CC=C1C=C XUDBVJCTLZTSDC-UHFFFAOYSA-N 0.000 description 1
- IIWJUSHBYDKYTI-UHFFFAOYSA-N 2-ethylhexyl 2-(hydroxymethyl)prop-2-enoate Chemical compound CCCCC(CC)COC(=O)C(=C)CO IIWJUSHBYDKYTI-UHFFFAOYSA-N 0.000 description 1
- WDQMWEYDKDCEHT-UHFFFAOYSA-N 2-ethylhexyl 2-methylprop-2-enoate Chemical compound CCCCC(CC)COC(=O)C(C)=C WDQMWEYDKDCEHT-UHFFFAOYSA-N 0.000 description 1
- NGOCAPPEAVAHQM-UHFFFAOYSA-N 2-fluoroprop-1-ene Chemical compound CC(F)=C NGOCAPPEAVAHQM-UHFFFAOYSA-N 0.000 description 1
- OMIGHNLMNHATMP-UHFFFAOYSA-N 2-hydroxyethyl prop-2-enoate Chemical compound OCCOC(=O)C=C OMIGHNLMNHATMP-UHFFFAOYSA-N 0.000 description 1
- LPLLVINFLBSFRP-UHFFFAOYSA-N 2-methylamino-1-phenylpropan-1-one Chemical compound CNC(C)C(=O)C1=CC=CC=C1 LPLLVINFLBSFRP-UHFFFAOYSA-N 0.000 description 1
- PSWSOAQTFFDDBM-UHFFFAOYSA-N 2-phenylethanamine Chemical compound NCCC1=CC=CC=C1.NCCC1=CC=CC=C1 PSWSOAQTFFDDBM-UHFFFAOYSA-N 0.000 description 1
- SMFDSFRYWRBNSQ-UHFFFAOYSA-N 2-prop-1-en-2-ylbenzenesulfonic acid Chemical compound CC(=C)C1=CC=CC=C1S(O)(=O)=O SMFDSFRYWRBNSQ-UHFFFAOYSA-N 0.000 description 1
- KFFWCQASVWGKLX-UHFFFAOYSA-N 2-prop-1-en-2-ylbenzoic acid Chemical compound CC(=C)C1=CC=CC=C1C(O)=O KFFWCQASVWGKLX-UHFFFAOYSA-N 0.000 description 1
- VHMICKWLTGFITH-UHFFFAOYSA-N 2H-isoindole Chemical compound C1=CC=CC2=CNC=C21 VHMICKWLTGFITH-UHFFFAOYSA-N 0.000 description 1
- LGUVDOBGXUFUAJ-UHFFFAOYSA-N 2c-t-19 Chemical compound CCCCSC1=CC(OC)=C(CCN)C=C1OC LGUVDOBGXUFUAJ-UHFFFAOYSA-N 0.000 description 1
- NGBBVGZWCFBOGO-UHFFFAOYSA-N 3,4-Methylenedioxyamphetamine Chemical compound CC(N)CC1=CC=C2OCOC2=C1 NGBBVGZWCFBOGO-UHFFFAOYSA-N 0.000 description 1
- YTEVSDFJQQJNEM-UHFFFAOYSA-N 3-(diethoxymethyl)-2-methyl-6-silylhex-2-enoic acid Chemical compound CCOC(OCC)C(CCC[SiH3])=C(C)C(O)=O YTEVSDFJQQJNEM-UHFFFAOYSA-N 0.000 description 1
- UIVRRNUEJAYDMX-UHFFFAOYSA-N 3-(diethoxymethylsilyl)propyl prop-2-enoate Chemical compound CCOC(OCC)[SiH2]CCCOC(=O)C=C UIVRRNUEJAYDMX-UHFFFAOYSA-N 0.000 description 1
- VLZDYNDUVLBNLD-UHFFFAOYSA-N 3-(dimethoxymethylsilyl)propyl 2-methylprop-2-enoate Chemical compound COC(OC)[SiH2]CCCOC(=O)C(C)=C VLZDYNDUVLBNLD-UHFFFAOYSA-N 0.000 description 1
- HHHPYRGQUSPESB-UHFFFAOYSA-N 3-(dimethoxymethylsilyl)propyl prop-2-enoate Chemical compound COC(OC)[SiH2]CCCOC(=O)C=C HHHPYRGQUSPESB-UHFFFAOYSA-N 0.000 description 1
- WHLXWNNASHWYEM-UHFFFAOYSA-N 3-[di(propan-2-yloxy)methylsilyl]propyl 2-methylprop-2-enoate Chemical compound CC(C)OC(OC(C)C)[SiH2]CCCOC(=O)C(C)=C WHLXWNNASHWYEM-UHFFFAOYSA-N 0.000 description 1
- PAOULKYBFBZLBP-UHFFFAOYSA-N 3-[di(propan-2-yloxy)methylsilyl]propyl prop-2-enoate Chemical compound CC(C)OC(OC(C)C)[SiH2]CCCOC(=O)C=C PAOULKYBFBZLBP-UHFFFAOYSA-N 0.000 description 1
- RSSKWJGDNCKSCC-UHFFFAOYSA-N 3-di(propan-2-yloxy)silylpropyl 2-methylprop-2-enoate Chemical compound CC(C)O[SiH](OC(C)C)CCCOC(=O)C(C)=C RSSKWJGDNCKSCC-UHFFFAOYSA-N 0.000 description 1
- KIUQKRVLTQTVDR-UHFFFAOYSA-N 3-di(propan-2-yloxy)silylpropyl prop-2-enoate Chemical compound CC(C)O[SiH](OC(C)C)CCCOC(=O)C=C KIUQKRVLTQTVDR-UHFFFAOYSA-N 0.000 description 1
- SLDXSSRFNABVCN-UHFFFAOYSA-N 3-diethoxysilylpropyl 2-methylprop-2-enoate Chemical compound CCO[SiH](OCC)CCCOC(=O)C(C)=C SLDXSSRFNABVCN-UHFFFAOYSA-N 0.000 description 1
- DACWUGOLTNQROR-UHFFFAOYSA-N 3-diethoxysilylpropyl prop-2-enoate Chemical compound CCO[SiH](OCC)CCCOC(=O)C=C DACWUGOLTNQROR-UHFFFAOYSA-N 0.000 description 1
- BZCWFJMZVXHYQA-UHFFFAOYSA-N 3-dimethoxysilylpropyl 2-methylprop-2-enoate Chemical compound CO[SiH](OC)CCCOC(=O)C(C)=C BZCWFJMZVXHYQA-UHFFFAOYSA-N 0.000 description 1
- HNVMCAHOYIOFAQ-UHFFFAOYSA-N 3-dimethoxysilylpropyl prop-2-enoate Chemical compound CO[SiH](OC)CCCOC(=O)C=C HNVMCAHOYIOFAQ-UHFFFAOYSA-N 0.000 description 1
- QZPSOSOOLFHYRR-UHFFFAOYSA-N 3-hydroxypropyl prop-2-enoate Chemical compound OCCCOC(=O)C=C QZPSOSOOLFHYRR-UHFFFAOYSA-N 0.000 description 1
- ZJWCURYIRDLMTM-UHFFFAOYSA-N 3-tributoxysilylpropyl 2-methylprop-2-enoate Chemical compound CCCCO[Si](OCCCC)(OCCCC)CCCOC(=O)C(C)=C ZJWCURYIRDLMTM-UHFFFAOYSA-N 0.000 description 1
- YFISHOAHNLGUEL-UHFFFAOYSA-N 3-tributoxysilylpropyl prop-2-enoate Chemical compound CCCCO[Si](OCCCC)(OCCCC)CCCOC(=O)C=C YFISHOAHNLGUEL-UHFFFAOYSA-N 0.000 description 1
- URDOJQUSEUXVRP-UHFFFAOYSA-N 3-triethoxysilylpropyl 2-methylprop-2-enoate Chemical compound CCO[Si](OCC)(OCC)CCCOC(=O)C(C)=C URDOJQUSEUXVRP-UHFFFAOYSA-N 0.000 description 1
- XDQWJFXZTAWJST-UHFFFAOYSA-N 3-triethoxysilylpropyl prop-2-enoate Chemical compound CCO[Si](OCC)(OCC)CCCOC(=O)C=C XDQWJFXZTAWJST-UHFFFAOYSA-N 0.000 description 1
- XDLMVUHYZWKMMD-UHFFFAOYSA-N 3-trimethoxysilylpropyl 2-methylprop-2-enoate Chemical compound CO[Si](OC)(OC)CCCOC(=O)C(C)=C XDLMVUHYZWKMMD-UHFFFAOYSA-N 0.000 description 1
- KBQVDAIIQCXKPI-UHFFFAOYSA-N 3-trimethoxysilylpropyl prop-2-enoate Chemical compound CO[Si](OC)(OC)CCCOC(=O)C=C KBQVDAIIQCXKPI-UHFFFAOYSA-N 0.000 description 1
- URFGSZVXJZMYHZ-UHFFFAOYSA-N 4-(2-aminoethyl)benzene-1,3-diol Chemical compound NCCC1=CC=C(O)C=C1O URFGSZVXJZMYHZ-UHFFFAOYSA-N 0.000 description 1
- JLBJTVDPSNHSKJ-UHFFFAOYSA-N 4-Methylstyrene Chemical compound CC1=CC=C(C=C)C=C1 JLBJTVDPSNHSKJ-UHFFFAOYSA-N 0.000 description 1
- NDWUBGAGUCISDV-UHFFFAOYSA-N 4-hydroxybutyl prop-2-enoate Chemical compound OCCCCOC(=O)C=C NDWUBGAGUCISDV-UHFFFAOYSA-N 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 description 1
- 201000003883 Cystic fibrosis Diseases 0.000 description 1
- JIGUQPWFLRLWPJ-UHFFFAOYSA-N Ethyl acrylate Chemical compound CCOC(=O)C=C JIGUQPWFLRLWPJ-UHFFFAOYSA-N 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 108091092566 Extrachromosomal DNA Proteins 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 241000243251 Hydra Species 0.000 description 1
- HETCEOQFVDFGSY-UHFFFAOYSA-N Isopropenyl acetate Chemical compound CC(=C)OC(C)=O HETCEOQFVDFGSY-UHFFFAOYSA-N 0.000 description 1
- 239000006142 Luria-Bertani Agar Substances 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 1
- GYCMBHHDWRMZGG-UHFFFAOYSA-N Methylacrylonitrile Chemical compound CC(=C)C#N GYCMBHHDWRMZGG-UHFFFAOYSA-N 0.000 description 1
- VKEQBMCRQDSRET-UHFFFAOYSA-N Methylone Chemical compound CNC(C)C(=O)C1=CC=C2OCOC2=C1 VKEQBMCRQDSRET-UHFFFAOYSA-N 0.000 description 1
- 238000006845 Michael addition reaction Methods 0.000 description 1
- YPKBVWZHVTZSPU-UHFFFAOYSA-N N-acetylamphetamine Chemical compound CC(=O)NC(C)CC1=CC=CC=C1 YPKBVWZHVTZSPU-UHFFFAOYSA-N 0.000 description 1
- 208000012868 Overgrowth Diseases 0.000 description 1
- 241000816823 Panellus luminescens Species 0.000 description 1
- 229920012266 Poly(ether sulfone) PES Polymers 0.000 description 1
- 239000004695 Polyether sulfone Substances 0.000 description 1
- 239000002262 Schiff base Substances 0.000 description 1
- 150000004753 Schiff bases Chemical class 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 description 1
- IAXXETNIOYFMLW-COPLHBTASA-N [(1s,3s,4s)-4,7,7-trimethyl-3-bicyclo[2.2.1]heptanyl] 2-methylprop-2-enoate Chemical compound C1C[C@]2(C)[C@@H](OC(=O)C(=C)C)C[C@H]1C2(C)C IAXXETNIOYFMLW-COPLHBTASA-N 0.000 description 1
- GIEOVLYOTBHPBV-UHFFFAOYSA-N [Na].BrC=C.C=CC#N Chemical compound [Na].BrC=C.C=CC#N GIEOVLYOTBHPBV-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000002099 adlayer Substances 0.000 description 1
- NDAUXUAQIAJITI-UHFFFAOYSA-N albuterol Chemical compound CC(C)(C)NCC(O)C1=CC=C(O)C(CO)=C1 NDAUXUAQIAJITI-UHFFFAOYSA-N 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- XYLMUPLGERFSHI-UHFFFAOYSA-N alpha-Methylstyrene Chemical compound CC(=C)C1=CC=CC=C1 XYLMUPLGERFSHI-UHFFFAOYSA-N 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000012062 aqueous buffer Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 238000011001 backwashing Methods 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 230000000721 bacterilogical effect Effects 0.000 description 1
- RFRXIWQYSOIBDI-UHFFFAOYSA-N benzarone Chemical compound CCC=1OC2=CC=CC=C2C=1C(=O)C1=CC=C(O)C=C1 RFRXIWQYSOIBDI-UHFFFAOYSA-N 0.000 description 1
- AOJOEFVRHOZDFN-UHFFFAOYSA-N benzyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCC1=CC=CC=C1 AOJOEFVRHOZDFN-UHFFFAOYSA-N 0.000 description 1
- GCTPMLUUWLLESL-UHFFFAOYSA-N benzyl prop-2-enoate Chemical compound C=CC(=O)OCC1=CC=CC=C1 GCTPMLUUWLLESL-UHFFFAOYSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- INLLPKCGLOXCIV-UHFFFAOYSA-N bromoethene Chemical compound BrC=C INLLPKCGLOXCIV-UHFFFAOYSA-N 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- SNPPWIUOZRMYNY-UHFFFAOYSA-N bupropion Chemical compound CC(C)(C)NC(C)C(=O)C1=CC=CC(Cl)=C1 SNPPWIUOZRMYNY-UHFFFAOYSA-N 0.000 description 1
- 229960001058 bupropion Drugs 0.000 description 1
- LSURRKWOANERMF-UHFFFAOYSA-N butyl 2-(hydroxymethyl)prop-2-enoate Chemical compound CCCCOC(=O)C(=C)CO LSURRKWOANERMF-UHFFFAOYSA-N 0.000 description 1
- CQEYYJKEWSMYFG-UHFFFAOYSA-N butyl acrylate Chemical compound CCCCOC(=O)C=C CQEYYJKEWSMYFG-UHFFFAOYSA-N 0.000 description 1
- PUAQLLVFLMYYJJ-ZETCQYMHSA-N cathinone Chemical compound C[C@H](N)C(=O)C1=CC=CC=C1 PUAQLLVFLMYYJJ-ZETCQYMHSA-N 0.000 description 1
- 229950002698 cathinone Drugs 0.000 description 1
- 150000008367 cathinones Chemical class 0.000 description 1
- 230000021164 cell adhesion Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- 238000005660 chlorination reaction Methods 0.000 description 1
- 239000013611 chromosomal DNA Substances 0.000 description 1
- WCZVZNOTHYJIEI-UHFFFAOYSA-N cinnoline Chemical compound N1=NC=CC2=CC=CC=C21 WCZVZNOTHYJIEI-UHFFFAOYSA-N 0.000 description 1
- 238000005352 clarification Methods 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 229920006147 copolyamide elastomer Polymers 0.000 description 1
- 229910001431 copper ion Inorganic materials 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 238000009295 crossflow filtration Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000010612 desalination reaction Methods 0.000 description 1
- 238000011033 desalting Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 150000005205 dihydroxybenzenes Chemical class 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- MHUWZNTUIIFHAS-CLFAGFIQSA-N dioleoyl phosphatidic acid Chemical class CCCCCCCC\C=C/CCCCCCCC(=O)OCC(COP(O)(O)=O)OC(=O)CCCCCCC\C=C/CCCCCCCC MHUWZNTUIIFHAS-CLFAGFIQSA-N 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229960005139 epinephrine Drugs 0.000 description 1
- MEGHWIAOTJPCHQ-UHFFFAOYSA-N ethenyl butanoate Chemical compound CCCC(=O)OC=C MEGHWIAOTJPCHQ-UHFFFAOYSA-N 0.000 description 1
- UIWXSTHGICQLQT-UHFFFAOYSA-N ethenyl propanoate Chemical compound CCC(=O)OC=C UIWXSTHGICQLQT-UHFFFAOYSA-N 0.000 description 1
- SYGAXBISYRORDR-UHFFFAOYSA-N ethyl 2-(hydroxymethyl)prop-2-enoate Chemical compound CCOC(=O)C(=C)CO SYGAXBISYRORDR-UHFFFAOYSA-N 0.000 description 1
- SUPCQIBBMFXVTL-UHFFFAOYSA-N ethyl 2-methylprop-2-enoate Chemical compound CCOC(=O)C(C)=C SUPCQIBBMFXVTL-UHFFFAOYSA-N 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 229960001582 fenfluramine Drugs 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- XUCNUKMRBVNAPB-UHFFFAOYSA-N fluoroethene Chemical compound FC=C XUCNUKMRBVNAPB-UHFFFAOYSA-N 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000012737 fresh medium Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000010559 graft polymerization reaction Methods 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 239000008235 industrial water Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000006799 invasive growth in response to glucose limitation Effects 0.000 description 1
- 125000003010 ionic group Chemical group 0.000 description 1
- 229940119545 isobornyl methacrylate Drugs 0.000 description 1
- QRXWMOHMRWLFEY-UHFFFAOYSA-N isoniazide Chemical compound NNC(=O)C1=CC=NC=C1 QRXWMOHMRWLFEY-UHFFFAOYSA-N 0.000 description 1
- 125000000555 isopropenyl group Chemical group [H]\C([H])=C(\*)C([H])([H])[H] 0.000 description 1
- LVHBHZANLOWSRM-UHFFFAOYSA-N itaconic acid Chemical compound OC(=O)CC(=C)C(O)=O LVHBHZANLOWSRM-UHFFFAOYSA-N 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- ORXQUAPZHKCCAX-UHFFFAOYSA-N lophophine Chemical compound COC1=CC(CCN)=CC2=C1OCO2 ORXQUAPZHKCCAX-UHFFFAOYSA-N 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005374 membrane filtration Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- FQPSGWSUVKBHSU-UHFFFAOYSA-N methacrylamide Chemical compound CC(=C)C(N)=O FQPSGWSUVKBHSU-UHFFFAOYSA-N 0.000 description 1
- RFUCOAQWQVDBEU-UHFFFAOYSA-N methyl 2-(hydroxymethyl)prop-2-enoate Chemical compound COC(=O)C(=C)CO RFUCOAQWQVDBEU-UHFFFAOYSA-N 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000013580 millipore water Substances 0.000 description 1
- 238000002715 modification method Methods 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- DPLUMPJQXVYXBH-UHFFFAOYSA-N n,n-diethyl-2-phenylethenamine Chemical compound CCN(CC)C=CC1=CC=CC=C1 DPLUMPJQXVYXBH-UHFFFAOYSA-N 0.000 description 1
- DNTMQTKDNSEIFO-UHFFFAOYSA-N n-(hydroxymethyl)-2-methylprop-2-enamide Chemical compound CC(=C)C(=O)NCO DNTMQTKDNSEIFO-UHFFFAOYSA-N 0.000 description 1
- VQGWOOIHSXNRPW-UHFFFAOYSA-N n-butyl-2-methylprop-2-enamide Chemical compound CCCCNC(=O)C(C)=C VQGWOOIHSXNRPW-UHFFFAOYSA-N 0.000 description 1
- YRVUCYWJQFRCOB-UHFFFAOYSA-N n-butylprop-2-enamide Chemical compound CCCCNC(=O)C=C YRVUCYWJQFRCOB-UHFFFAOYSA-N 0.000 description 1
- DNZSNCLTAOETCO-UHFFFAOYSA-N n-tert-butyl-2-methylprop-2-enamide;3-methoxycarbonylbut-3-enoic acid Chemical compound COC(=O)C(=C)CC(O)=O.CC(=C)C(=O)NC(C)(C)C DNZSNCLTAOETCO-UHFFFAOYSA-N 0.000 description 1
- XFHJDMUEHUHAJW-UHFFFAOYSA-N n-tert-butylprop-2-enamide Chemical compound CC(C)(C)NC(=O)C=C XFHJDMUEHUHAJW-UHFFFAOYSA-N 0.000 description 1
- 150000002790 naphthalenes Chemical class 0.000 description 1
- 239000003345 natural gas Substances 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- RPQRDASANLAFCM-UHFFFAOYSA-N oxiran-2-ylmethyl prop-2-enoate Chemical compound C=CC(=O)OCC1CO1 RPQRDASANLAFCM-UHFFFAOYSA-N 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- PNJWIWWMYCMZRO-UHFFFAOYSA-N pent‐4‐en‐2‐one Natural products CC(=O)CC=C PNJWIWWMYCMZRO-UHFFFAOYSA-N 0.000 description 1
- 238000005373 pervaporation Methods 0.000 description 1
- VGPJCNYMPYIQGO-UHFFFAOYSA-N phamine Natural products O=C(OC)CCCN1C(=O)c2c(-c3c1cccc3)cc1OCOc1c2 VGPJCNYMPYIQGO-UHFFFAOYSA-N 0.000 description 1
- QIWKUEJZZCOPFV-UHFFFAOYSA-N phenyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OC1=CC=CC=C1 QIWKUEJZZCOPFV-UHFFFAOYSA-N 0.000 description 1
- WRAQQYDMVSCOTE-UHFFFAOYSA-N phenyl prop-2-enoate Chemical compound C=CC(=O)OC1=CC=CC=C1 WRAQQYDMVSCOTE-UHFFFAOYSA-N 0.000 description 1
- SONNWYBIRXJNDC-VIFPVBQESA-N phenylephrine Chemical compound CNC[C@H](O)C1=CC=CC(O)=C1 SONNWYBIRXJNDC-VIFPVBQESA-N 0.000 description 1
- 229960001802 phenylephrine Drugs 0.000 description 1
- 238000009832 plasma treatment Methods 0.000 description 1
- 229920002589 poly(vinylethylene) polymer Polymers 0.000 description 1
- 229920003242 poly[1-(trimethylsilyl)-1-propyne] Polymers 0.000 description 1
- 229920006254 polymer film Polymers 0.000 description 1
- 239000003505 polymerization initiator Substances 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- QVQPFHVJHZPVDM-UHFFFAOYSA-N prop-1-en-2-yl benzoate Chemical compound CC(=C)OC(=O)C1=CC=CC=C1 QVQPFHVJHZPVDM-UHFFFAOYSA-N 0.000 description 1
- PDBWEHKCAUAROT-UHFFFAOYSA-N prop-1-en-2-yl butanoate Chemical compound CCCC(=O)OC(C)=C PDBWEHKCAUAROT-UHFFFAOYSA-N 0.000 description 1
- GQHNKWZNJBZCMN-UHFFFAOYSA-N propyl 2-(hydroxymethyl)prop-2-enoate Chemical compound CCCOC(=O)C(=C)CO GQHNKWZNJBZCMN-UHFFFAOYSA-N 0.000 description 1
- NHARPDSAXCBDDR-UHFFFAOYSA-N propyl 2-methylprop-2-enoate Chemical compound CCCOC(=O)C(C)=C NHARPDSAXCBDDR-UHFFFAOYSA-N 0.000 description 1
- PNXMTCDJUBJHQJ-UHFFFAOYSA-N propyl prop-2-enoate Chemical compound CCCOC(=O)C=C PNXMTCDJUBJHQJ-UHFFFAOYSA-N 0.000 description 1
- 239000012460 protein solution Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- JWVCLYRUEFBMGU-UHFFFAOYSA-N quinazoline Chemical compound N1=CN=CC2=CC=CC=C21 JWVCLYRUEFBMGU-UHFFFAOYSA-N 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 239000005060 rubber Substances 0.000 description 1
- 229960002052 salbutamol Drugs 0.000 description 1
- 229910052594 sapphire Inorganic materials 0.000 description 1
- 239000010980 sapphire Substances 0.000 description 1
- 238000006748 scratching Methods 0.000 description 1
- 230000002393 scratching effect Effects 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 229920000468 styrene butadiene styrene block copolymer Polymers 0.000 description 1
- 239000002344 surface layer Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 229920001897 terpolymer Polymers 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 229960003732 tyramine Drugs 0.000 description 1
- 238000000870 ultraviolet spectroscopy Methods 0.000 description 1
- KOZCZZVUFDCZGG-UHFFFAOYSA-N vinyl benzoate Chemical compound C=COC(=O)C1=CC=CC=C1 KOZCZZVUFDCZGG-UHFFFAOYSA-N 0.000 description 1
- 230000004393 visual impairment Effects 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
Images
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D67/00—Processes specially adapted for manufacturing semi-permeable membranes for separation processes or apparatus
- B01D67/0081—After-treatment of organic or inorganic membranes
- B01D67/0093—Chemical modification
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D69/00—Semi-permeable membranes for separation processes or apparatus characterised by their form, structure or properties; Manufacturing processes specially adapted therefor
- B01D69/02—Semi-permeable membranes for separation processes or apparatus characterised by their form, structure or properties; Manufacturing processes specially adapted therefor characterised by their properties
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D69/00—Semi-permeable membranes for separation processes or apparatus characterised by their form, structure or properties; Manufacturing processes specially adapted therefor
- B01D69/12—Composite membranes; Ultra-thin membranes
- B01D69/125—In situ manufacturing by polymerisation, polycondensation, cross-linking or chemical reaction
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D71/00—Semi-permeable membranes for separation processes or apparatus characterised by the material; Manufacturing processes specially adapted therefor
- B01D71/06—Organic material
- B01D71/58—Other polymers having nitrogen in the main chain, with or without oxygen or carbon only
- B01D71/60—Polyamines
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2323/00—Details relating to membrane preparation
- B01D2323/38—Graft polymerization
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2325/00—Details relating to properties of membranes
- B01D2325/28—Degradation or stability over time
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2325/00—Details relating to properties of membranes
- B01D2325/48—Antimicrobial properties
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/31504—Composite [nonstructural laminate]
- Y10T428/31678—Of metal
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/31504—Composite [nonstructural laminate]
- Y10T428/31855—Of addition polymer from unsaturated monomers
Definitions
- the present invention relates in general to the field of membranes for water purification, and more particularly to the deposition of polymers and modification of membrane surfaces to reduce biofilm formation on membranes.
- hydrophilic polymers to coat and modify membrane surfaces to reduce membrane fouling, scaling and/or biofouling, specifically reducing biofilm formation, salt crystallization on a membrane's surface, or the accumulation of other foulants (e.g., natural organic matter, colloidal matter, emulsified oil droplets, and other types of foulants that may be found in feed streams of interest).
- other foulants e.g., natural organic matter, colloidal matter, emulsified oil droplets, and other types of foulants that may be found in feed streams of interest.
- fouling occurs when impurities in water deposit on the surface of the membrane and is also seen when the internal pore structure of the membrane is obstructed.
- Biofouling is a subset of fouling where bacterial colonies undergo proliferation and deposition on the membrane. The bacteria, in turn, form biofilms with significant mass transfer resistance through bacterial secretion of extracellular polymeric substances on the membrane surface and, if the membranes are porous, into the membrane pore structure.
- Biofilms are remarkably difficult to treat with antimicrobials. In some cases the antimicrobial compositions may be readily inactivated or fail to penetrate into the biofilm. Furthermore, the microorganisms distributed throughout the biofilm may be from different geographic locales and the same species microorganisms may have different characteristics depending on the geographical location in the biofilm. Biofilms are often comprised of a variety of different species which may offer protection to one another. Microorganisms may also express new, and sometimes more virulent phenotypes when grown within a biofilm, allowing for alterations in colony morphology, metabolism, and growth rate in the sessile state to improve microbial resistance.
- microorganisms within the biofilm may have an increased (e.g., up to 1000-fold higher) resistance to antimicrobial compounds, even though these same microorganisms are sensitive to these agents if grown under planktonic conditions.
- Such phenotypes may not have been detected in the past because the organisms were grown on rich nutrient media under planktonic conditions.
- the growth conditions are quite different, particularly in the depths of biofilms, where nutrients and oxygen are usually limited, and waste products from neighbors can be toxic.
- microorganisms found at the bottom of the biofilm look and act differently from microorganisms located at the surface.
- United States Patent Publication Number 2006/0009550 teaches a surface modification method involving the addition of a polymerization initiator composition comprising a dihydroxyphenyl terminated halide, followed by reaction with a monomer to form a surface bound polymer.
- the modified surfaces have a variety of medical and industrial applications involving prevention of cell and protein adhesion on medical devices and other surfaces. These modified surfaces are used to control and prevent algal and bacterial growth on water lines used for industrial and drinking water.
- United States Patent Publication Number 2008/0149566 discloses a method of coating a surface with a multifunctional biocoating by contacting a portion of a substrate with an alkaline solution of a surface modifying agent (SMA) like dopamine so as to introduce reactive groups on the surface. Furthermore, the application teaches a method for adding a secondary reactive moiety to the SMA treated surface to yield modified substrates with specific functionalities.
- SMA surface modifying agent
- the present invention provides methods and compositions to alleviate fouling, scaling, and/or biofilm formation (i.e., biofouling) of conventional polymeric membranes using a novel polymer deposition.
- the present invention provides a highly hydrophilic polymer, polydopamine, which can be deposited with strong adhesion onto virtually any surface.
- the present invention provides a substrate for the attachment (covalently and/or non-covalently) of molecules to provide specific membrane surface chemistries and properties.
- the present invention also provides a highly hydrophilic polymer that can further react with metal ions to form metallic particles on the membrane surface via an electroless metallization mechanism.
- the present invention provides methods and compositions to alleviate biofilm formation on membranes using hydrophilic molecule attachment (such as poly(ethylene glycol)); attachment of metal ions (e.g., silver/copper) to polydopamine; and attachment of other molecules to the membrane surface (e.g., furanones can reduce bacterial proliferation on surfaces).
- hydrophilic molecule attachment such as poly(ethylene glycol)
- metal ions e.g., silver/copper
- other molecules to the membrane surface e.g., furanones can reduce bacterial proliferation on surfaces.
- the present invention also provides methods and compositions to alleviate fouling and/or scaling by tuning pertinent membrane surface properties through the attachment of long chain polymers (e.g., poly(ethylene glycol) (PEG) and other hydrophilic or hydrophobic polymers) to the polydopamine deposition layer.
- PEG poly(ethylene glycol)
- the polydopamine of the present invention increases the membrane resistance to biofilm formation, fouling and/or scaling, which, in turn, results in higher membrane fluxes. Furthermore, the present invention may be tailored to specific properties through the addition of compositions from a library of possible compounds available to covalently attach to the polydopamine layer, making it an extremely versatile modification.
- the present invention also provides a method for treating and/or coating existing surfaces or membrane support through non-specific adhesion of polydopamine to any surface, therefore allowing modification of all wetted parts of a membrane module or membrane treatment system.
- Another advantage of the polydopamine deposition of the present invention is its ease of applicability to membrane modules and other wetted parts of membrane treatment systems, even in large-scale applications.
- all the wetted module parts that are susceptible to fouling can be modified by the present invention.
- polydopamine is applicable to practically any membrane, regardless of membrane material, whereas most surface modification techniques have only been accomplished using one specific membrane. Polydopamine can also react with many different conjugated molecules, which allows membrane surface properties to be further tuned to specific applications.
- the deposition process occurs by simply dissolving dopamine in an alkaline water solution (e.g., 8-14 pH) and circulating the dopamine solution through a membrane module housing for a period of time (e.g., 30 minutes).
- an alkaline water solution e.g. 8-14 pH
- most membranes surface modification result in a dramatic pure water flux loss, due to the polymer layer increasing the membrane's overall mass transfer resistance.
- the polydopamine-coated membranes of the present invention lose relatively little pure water flux when compared to uncoated membranes, as the polydopamine coating layer is extremely thin, e.g., polydopamine coating layers as thin as approximately 5 nm are possible on polysulfone, a common polymer for ultrafiltration membranes.
- the present invention provides a method of depositing a coating material to reduce or prevent fouling, scaling, and/or biofilm formation on a surface by adding a dopamine coating material to a liquid solvent to form a solution mixture, adjusting the pH of the solution mixture to an alkaline pH (e.g., 8, 9, or 10) and dissolving the dopamine coating material in the liquid solvent.
- the solution mixture is then placed into contact with one or more surfaces to form a dopamine coating on the surface to reduce fouling, scaling, or biofilm formation.
- the dopamine coating may form a polydopamine coating and in addition may include one or more polymers, one or more polar sugars, one or more polar salts, one or more polar organic molecules, one or more polar —OH containing molecules, one or more polar —NH 2 containing molecules, one or more —SH containing molecules, one or more halide-containing molecules, one or more polar O containing molecules, one or more polar molecules, one or more polar hydrophilic molecules, one or more molecules comprising at least one polar group or combinations thereof.
- the dopamine coating may include one or more silver, zinc, copper, metal ions, alloy ions, nanoparticles, metal nanoparticles, inorganic molecules or combinations thereof.
- the present invention includes a liquid separation apparatus having reduced fouling, scaling, and/or biofilm formation including a purification membrane and a polydopamine layer deposited on the purification membrane to form a polydopamine coated membrane to reduce fouling, scaling, and/or biofilm formation, wherein the polydopamine layer increases the hydrophilicity of the purification membrane and the polydopamine coated membrane has high water flux.
- One or more containers are positioned on different sides of the polydopamine coated membrane to contain the separated liquid.
- the present invention also includes a polydopamine coated purification membrane system for modification of conventional purification membranes to reduce fouling, scaling, and/or biofilm formation having a dopamine solution disposed in a feed tank, a pump connected to the feed tank to move the dopamine solution, a membrane inlet connection connected to the pump to a membrane that allows the dopamine solution to be deposited on the membrane, and a membrane outlet connection to connect the membrane to the feed tank to return the dopamine solution to the feed tank.
- FIG. 1 is a schematic of the structure of dopamine and assumed structure of polydopamine
- FIG. 2 is a plot of the pure water permeance of an ultrafiltration (UF) polysulfone membrane modified with different polydopamine deposition times and polydopamine deposition thickness on a Udel polysulfone thin film as measured by ellipsometry;
- UF ultrafiltration
- FIGS. 3A , 3 B, 3 C, 3 D, 3 E, 3 F, and 3 G are graphs of non-ionic oil emulsion fouling studies on various polydopamine and PEG modified and unmodified microfiltration (MF), ultrafiltration (UF), nanofiltration (NF) and reverse osmosis (RO) membranes.
- MF microfiltration
- UF ultrafiltration
- NF nanofiltration
- RO reverse osmosis
- the results for an unmodified membrane are labeled “Unmodified” in this figure.
- Results from membranes modified with polydopamine alone are labeled “PDOPA”
- results from membranes modified with dopamine and subsequently also modified with poly(ethylene glycol) (PEG) are labeled “PDOPA-g-PEG”.
- FIG. 3 h presents dodecyl trimethylammonium bromide and decane emulsion fouling for modified and unmodified RO membranes
- FIG. 4 is a plot comparing pure water flux through nascent (unfouled) and fouled (after rinsing) polydopamine and PEG modified and unmodified MF, UF, NF, and RO membranes;
- FIG. 5 is a graph of the adhesion of Pseudomonas aeruginosa to modified and unmodified membranes as measured by the luminescent intensity of genetically modified Pseudomonas aeruginosa.
- FIG. 6 illustrates a crossflow system having a feed tank connected to membrane cells
- FIG. 7 is a schematic of a modified crossflow system for polydopamine deposition and subsequent PEG adhesion.
- molecule is used to refer to a combination of two or more atoms in a definite arrangement held together by covalent chemical bonds and is generally considered the smallest particle of a pure substance that still retains its composition and chemical properties.
- water flux or “flux” is used to refer to the volume of solution (e.g., water, clean water, permeate solution, etc.) flowing through a given membrane area during a given time. Measurement of the amount of water or permeate solution that flows through a membrane.
- bacterial biofilms are organized, sessile collections of microorganisms that commonly develop on water purification, wastewater treatment, and bioreactor membranes and reduce flux and compromise rejection properties.
- Biofilm growth provides a number of advantages to its constituent organisms over growth in the planktonic state, including enhanced nutrient access, improved antimicrobial resistance, and synergistic associations with other nearby cells.
- the biofilm is initiated by a conditioning film forms on the substrate surface, usually comprised of proteins and other organic matter. Bacteria are brought close to the surface by fluid flow where they can adhere (reversibly and irreversibly) to the conditioned surface. The microorganisms grow and divide, colonizing the surface and producing large quantities of sticky extracellular matrix polymers, until they undergo detachment to the planktonic state to colonize at other locales.
- Naturally-occurring biofilms are a poorly-understood complex of many bacterial species.
- Pseudomonas aeruginosa a gram-negative, rod-shaped organism that can be found in nearly all natural waters, including drinking reserves and widely known to prolifically foul surfaces, forming robust biofilms due to its rapid rate of reproduction.
- Pseudomonas aeruginosa is an opportunistic human pathogen, responsible for biofilm formation in medical devices and infections of many hospital patients, especially those suffering from burn wounds and cystic fibrosis.
- biofilm formation is typically addressed with feedwater chlorination (e.g., in water purification) and mechanical cleaning/backwashing of the membrane (e.g., both water purification and membrane bioreactor systems). If conditioning film formation and bacterial adhesion can be reduced, fouling biofilms should be slower to develop on membranes.
- the present invention provides a polydopamine deposition on a variety of surfaces and allows surface modification of a variety of membranes, regardless of membrane material, e.g., microfiltration: polypropylene, poly(vinylidene fluoride), poly(tetrafluoroethylene), ultrafiltration: polysulfone, poly(ether sulfone), nanofiltration: polyamide and reverse osmosis: polyamide. These surfaces were examined for their effectiveness against Pseudomonas aeruginosa attachment.
- modified or substituted dopamine can be used to form a substituted polydopamine on the membrane surface.
- the substitution may be one or more lower alkyl groups, alkenyl groups, amino groups, aryl groups, alkylaryl groups, halogen groups, halo groups, haloalkyl groups, phosphoryl groups or combination thereof.
- the substituted polydopamine may have one or more groups and the groups may be similar or different groups.
- the individual monomer, copolymers, subunits or polymers may be substituted with one or more molecules, groups or atoms.
- the number, position, location and type of modification may be varied by the skilled artisan.
- the modifications may include the addition of one or more of the following groups: lower alkyl, alkenyl, amino, aryl, alkylaryl, halogen, halo, haloalkyl, phosphoryl or combination thereof.
- the present invention includes a deposition method used to treat membranes with dopamine to form polydopamine on the membrane surface and in the case of porous membranes, inside the membrane pores.
- This method is advantageous over other modifications because of its ease of applicability to virtually any membrane support.
- Polydopamine nonspecifically adheres to virtually any surface with which it comes into contact.
- the deposition process occurs by dissolving dopamine in an alkaline water solution (e.g., from a pH of about 8 to a pH of 14) and immersing a membrane into the solution for a certain period of time (e.g., 1 minute to multiple days).
- the length of time of exposure of the membrane to the dopamine solution may be varied to change the amount of dopamine (and therefore polydopamine) deposited on the membrane surface.
- TIS tris(hydroxymethyl)aminomethane
- the dopamine concentration can be varied, as can the buffer solution used and that the dopamine can be applied from an alkaline aqueous solution with no buffer if desired, to vary the amount of dopamine (and therefore polydopamine) deposited onto the membrane.
- the present invention includes layers and composition having dopamine/polydopamine as an additive.
- the dopamine/polydopamine is in the form of an additive, the actual dopamine/polydopamine concentration will be a percentage of the total concentration and may be from 0.001 to 50 percent. When the percentage of dopamine/polydopamine is above 50 percent, dopamine/polydopamine will be considered the polymer and any additional compositions will be considered as the additive.
- the dopamine/polydopamine additive concentration may be 0.1, 0.2, 0.3, 0.4, 0.5, 1, 2, 3, 4, 5, 10, 15, 20, 30, 40, to 50 percent. As the percentage listed here are for example it should be understood that the skilled artisan contemplates the use of as an additive for each and every value listed between 0.001 and 50, e.g., 37.45% and 14.96%.
- the present inventors recognized that most membranes that undergo a surface modification usually exhibit a significant pure water flux loss, as the modification usually involves adding a polymer layer that remarkably increases a membrane's overall mass transfer resistance.
- this loss in water flux upon modifying, the surface of a membrane the skilled artisan is referred to Ju et al., Journal of Membrane Science, volume 307, pp. 260-267 (2008) which shows a reduction in water permeance through the ultrafiltration membrane from 141 L/(m 2 h bar) in an unmodified membrane to 36 L/(m 2 h bar) in a membrane which has been modified with poly(ethylene glycol)-type materials.
- Polydopamine modified membranes can be simply engineered to lose relatively little pure water flux when compared to uncoated membranes, as the amount of polydopamine deposited on the membrane is very small.
- delamination is generally a problem when using a highly hydrophilic polymer coating on a hydrophobic membrane, as the hydrophilic polymer coating will swell in water.
- polydopamine e.g., the dopamine monomer contains two hydroxyl groups
- the chemical structure of polydopamine most likely leads to strong physical bonding with membrane supports. These physical bonds insure high polydopamine binding so that delamination of the coating layer does not occur. Physical evidence of this strong binding was observed when a polydopamine modified polysulfone UF membrane was sonicated under extreme acidic conditions (3N HCl) for 5 minutes without visual loss of the polydopamine layer.
- polydopamine deposition can be used on a variety of surfaces and allows surface modification to a variety of membranes, regardless of membrane material. Most surface modification techniques used in the art have only been accomplished using one specific type of membrane. Furthermore, the present inventors recognized that the hydrophilicity of polydopamine rivals that of poly(ethylene-glycol)-modified surfaces (as confirmed by contact angle measurements), which have been used extensively as anti-fouling surface modifiers.
- the present inventors recognized that in order for sufficient polydopamine to deposit on a membrane surface it takes a significant amount of time since the oxidation reaction to convert dopamine to polydopamine and the deposition are relatively slow processes. For example, the present inventors used samples that had been immersed in a dopamine solution for 60 minutes for use in studies of reducing biofilm formation and anti-fouling. Although this is not exceedingly long, for industrial practicality, shorter or longer immersion times may be deemed optimal.
- the membrane immersion in the dopamine solution may be varied from 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 50, 60, 120 or more than 120 minutes depending on factors such as solution pH, dopamine concentration, substrate material temperature, and so forth.
- the present inventors recognized that the polydopamine structure is also of interest in oxidative (alkaline) environments, as properly conjugated molecules will covalently bond to it and allow the use of the polydopamine as an intermediate layer between a hydrophobic membrane and a hydrophilic coating.
- the polydopamine layer improves adhesion to the membrane support, allowing long-term membrane operation.
- the hydrophilicity of the polydopamine structure increases the wettability of polydopamine coated hydrophobic membranes and reduces defects in a hydrophilic coating layer.
- a membrane coating layer further reduces fouling by not allowing biofilm formation on the porous structure of the underlying membrane.
- the present invention provides a polydopamine deposition layer over a substrate layer and allows the substrate to be a variety of substances and materials.
- the polydopamine deposition layer of the present invention provides a high hydrophilicity and is suited to alleviate biofilm formation when used to modify water purification membrane surfaces.
- Polydopamine a hydrophilic polymer
- RO reverse osmosis
- NF nanofiltration
- UF ultrafiltration
- dopamine can positively influence the fouling characteristics of these membranes, it should also positively influence the fouling characteristics of other membranes and filter media, such as microfiltration (MF) membranes.
- the flux of the polydopamine coated membrane is the same as the uncoated membrane and, therefore, exhibits 100% flux when compared to the uncoated membrane.
- the polydopamine modification can, in some instances with hydrophobic microfiltration membranes or large pore ultrafiltration membranes, impart added wettability to the pore structure, which, when coupled with a negligible decrease in its pore size, leads to an effective increase in pure water flux over that of the unmodified membrane.
- the polydopamine coated membrane may have a high flux given the presence of a coating on the membrane and range between 150% and 0% flux when compared to the flux of an unmodified membrane.
- the polydopamine, the membrane, or both may be further modified by the addition of one or more of the following: nanometals, nanoparticles, halogens, hydroxyl groups, lower alkyl groups, lower alkoxy groups, monocyclic aryl, lower acyl groups, one or more functional groups chosen from ROOH, ROSH, RSSH, OH, SO 3 H, SO 3 R, SO 4 R, COOH, NH 2 , NHR, NR 2 , CONH 2 , and NH—NH 2 , wherein R denotes: linear or branched hydrocarbon-based chains, capable of forming at least one carbon-based ring, being saturated or unsaturated; alkylenes, siloxanes, silanes, ethers, polyethers, thioethers, silylenes, silazanes and combinations thereof.
- the support membrane used for polydopamine modification may include one or more of the following: poly(methyl methacrylate)s, polystyrenes, polycarbonates, polyimides, epoxy resins, cyclic olefin copolymers, cyclic olefin polymers, acrylate or methacrylate polymers, polyethylene terephthalate, polyphenylene vinylene, polyether ether ketone, poly (N-vinylcarbazole), acrylonitrile-styrene copolymer, or polyetherimide poly(phenylenevinylene), polysulfones, sulfonated polysulfones, copolymers of styrene and acrylonitrile, poly(tetrafluoroethylene), poly(ethylene-co-propylene-co-diene), poly(arylene oxide), polycarbonate, cellulose acetate, piperazine-containing polymers, polyelectrolytes, styrene-containing copo
- a membrane coating layer further reduces fouling by not allowing foulants to come into contact with the porous structure of the underlying membrane.
- the binding of hydrophilic layers to hydrophobic membranes also serves a practical purpose in other membrane applications, including pervaporation and gas separations, in which the swellability of the hydrophilic polymer is an issue.
- FIG. 1 is a schematic of the structure of dopamine and the assumed structure of polydopamine.
- the dopamine self-polymerization reaction changed the color of the solution from transparent red to dark brown in less than one hour and the deposited polydopamine was visible on the membrane surface after only a few minutes of immersion time. This deposited layer was tightly bound to the surface of the membrane, as there was no membrane discoloration even after sonication under 3N HCl for about 5 minutes. In addition, scratching the membrane surface did not visibly remove the deposited layer.
- the present invention also provides other amine substituted benzenediol compositions may be used.
- the present invention may use any aromatic dihydroxy group-containing molecule to form a membrane modifying agent.
- the aromatic molecule may contain 3 to 8 carbons and include one or more hetero atoms, e.g., benzothiazole, benzisoxazole, benzoxazole, indazole, purine, benzimidazole, benzo[c]thiophene, benzothiophene, isoindole, indole, isobenzofuran, benzofuran, naphthalene, naphthalene derivatives, quinoline, quinazoline, cinnoline, isoquinoline and substations and modifications thereof.
- hetero atoms e.g., benzothiazole, benzisoxazole, benzoxazole, indazole, purine, benzimidazole, benzo[c]thiophene, benzothiophene, isoindole, indole, isobenzofuran, benzofuran, naphthalene, naphthalene derivatives, quinoline
- dopamine or other aromatic dihydroxy and amine-containing molecules could be copolymerized or one member of a multi-monomer composition with a variety of different molecules containing aromatic dihydroxy, amine, or thiol functionality. These polymers can also be used to modify membrane surfaces.
- FIG. 2 is a plot of the permeance of UF polysulfone membranes with different polydopamine deposition times.
- FIG. 2 also presents dopamine deposition on thin, nonporous polysulfone (Udel) films as a function of immersion time (as measured by ellipsometry).
- Water transport through a polydopamine-modified polysulfone membrane was characterized as a function of membrane immersion time in the dopamine polymerization solution. The water flux decreased with increasing immersion time, as a larger amount of polydopamine was allowed to deposit on the membrane.
- PDOPA forms an extraordinarily thin film at low solution contact time ( ⁇ 5 nm at 30 m), which leads to small decreases in membrane flux.
- Table 1 illustrates decane-in-water captive bubble contact angles for polysulfone membranes subjected to various dopamine deposition times. Because of a spontaneous, fast polydopamine deposition, a dramatic increase in the polysulfone membrane surface hydrophilicity was seen. As presented in the above Table 1, a polysulfone UF membrane contact angle significantly decreased after only 10 minutes (0.16 hours) of dopamine immersion. The contact angle for membranes immersed for larger periods of time indicate that the surface hydrophilicity remained unaffected after the initial polydopamine deposition occurs. A similar increase in surface hydrophilicity was exhibited for other membranes studied, as shown in Table 2. This increase in surface hydrophilicity had a dramatic impact on membrane fouling resistance.
- the samples include an XLE reverse osmosis membrane (XLE RO), an NF-90 nanofiltration membrane (NF-90), a polypropylene microfiltration membrane (PP MF), a poly(tetrafluoroethylene) microfiltration membrane (PTFE MF), and a poly(vinylidene fluoride) microfiltration membrane (PVDF MF).
- XLE RO XLE reverse osmosis membrane
- NF-90 NF-90
- PP MF polypropylene microfiltration membrane
- PTFE MF poly(tetrafluoroethylene) microfiltration membrane
- PVDF MF poly(vinylidene fluoride) microfiltration membrane
- This constriction is also of interest (e.g., immersion times>16 hours), as polydopamine is capable of forming a highly hydrogen bonded network, with potentially unique separation properties in areas such as gas separations or water desalting applications or other water purification applications.
- FIGS. 3A , 3 B, 3 C, 3 D, 3 E, 3 F, 3 G, and 3 H are graphs of membrane fouling studies using either a nonionic oil emulsion (1500 ppm oil-water emulsion (1350 ppm vegetable oil plus 150 ppm DC-193 surfactant), FIGS. 3A-G ) or a positively-charged oil emulsion (150 ppm oil-water emulsion (135 ppm decane plus 15 ppm dodecyl trimethyl ammonium bromide (DTAB)), FIG. 3H ).
- NF and RO membranes reject ions, and therefore fouling feed water involving these membranes also contained 2000 ppm NaCl.
- a 1 hour polydopamine immersion time was chosen as a standard for MF membranes modified in this study; a 45 minute deposition time was used for UF membranes, and a 30 minute deposition time was used for the NF and RO membranes, except in FIG. 3H , where a polydopamine deposition time of 1.5 hours was used. These deposition times ensured that all modified membranes retained at least 80% of their respective unmodified membranes' pure water fluxes and significant changes in membrane surface properties (i.e., contact angle) were observed.
- PEG grafting to the polydopamine layer was accomplished using a 1 hour grafting time of a 5 kDa amine-terminated PEG.
- the polydopamine-modified membranes (termed “PDOPA” in these figures) and PEG grafted onto the polydopamine-modified membranes (termed “PDOPA-g-PEG” in these figures) outperformed their unmodified counterparts in these oil-emulsion fouling trials.
- FIG. 3A which presents modified and unmodified polysulfone UF membrane fouling, shows that, during most of this study, the polydopamine-modified membrane has a flux more than 2 times higher than the unmodified membrane while exhibiting similar organic rejection after one hour of filtration.
- PEG grafting to the polydopamine layer results in a slight improvement in flux over the polydopamine-modified membrane.
- PEG grafting to MF membranes leads to a considerable improvement in flux over both PDOPA modified membranes and unmodified membranes (as evidenced in FIGS. 3B , F, and G), whereas polydopamine depositions leads to only a slight improvement in flux over unmodified membranes, but a significant increase in organic rejection.
- PEG grafting to the polydopamine layer does not significantly improve membrane flux over polydopamine deposition alone. However, this may be due to a modest decrease in pure water permeance associated with the PEG grafting.
- 3H also shows the efficacy of polydopamine and PEG grafting to the polydopamine layer on a RO membrane to reduce fouling of a very aggressive, positively-charged decane-DTAB emulsion.
- RO membranes have a negative surface charge due to an excess of carboxylic moieties as a result of their polymerization chemistry. Therefore, positively-charged foulants are electrostatically attracted to the membrane surface, which leads to dramatic fouling.
- the modifications, in particular the PEG grafting lead to lower fouling and higher flux throughout the course of the filtration of this positively-charged emulsion.
- ions are rejected to a significant degree by NF and RO membranes.
- salt rejection of unmodified polyamide-based RO and NF membranes is lower than that of their respective PDOPA modified membranes when no organics are present in the feed stream.
- the unmodified RO and NF membranes exhibit slightly higher salt rejection in fouling experiments than PDOPA modified membranes. This is most likely caused by higher amounts of oil adsorption in the unmodified polyamide separating layer. This adsorption leads to a higher mass-transfer resistance, which leads to lower salt permeability in the membrane.
- FIG. 4 presents the ratio of pure water permeance before (P w,o ) and after (P w,f ) the non-ionic oil emulsion filtrations presented in FIG. 3 of unmodified, PDOPA modified, and PDOPA-g-PEG modified MF, UF, NF, and RO membranes.
- the membranes Prior to collecting the post-fouled membrane pure water permeance, the membranes were rinsed (to remove any unbound foulants) with pure water.
- a perfectly non-fouling membrane would have an irreversible fouling index (defined here as the ratio of the post-fouled membrane pure water permeance (P w,f ) to pre-fouled pure water permeance (P w,o )) of 1.
- Polydopamine greatly enhanced the irreversible fouling index of the membranes.
- an unmodified polysulfone UF membrane retained only 1% of its pure water permeance after 1 h of oil emulsion fouling
- a polydopamine modified UF membrane retained 18% of its initial permeance
- NF and RO modified membranes exhibited improved irreversible fouling resistance over their unmodified counterparts as well.
- BSA bovine serum albumin
- Polyamide RO and NF membranes were found to have high fluorescent intensity at the same emission wavelength as fluorescein, so rhodamine tagging was used in this study. Remarkably, 2-3 orders of magnitude decrease in protein adhesion is observed after modification for the UF and MF membranes. Furthermore, PDOPA-g-PEG modified membranes exhibit better resistance to protein adhesion than PDOPA modified membranes. This protein adhesion decrease is consistent with the generally accepted link between membrane hydrophilicity and protein adhesion resistance 2 . Furthermore, PDOPA-g-PEG modified surfaces have shown excellent protein adhesion resistance in other studies, which explains the PDOPA-g-PEG modified membranes' low adhesion characteristics 3,4 . These data clearly show the efficacy of polydopamine deposition and further PEG grafting to reduce protein adhesion to membranes, which is a critical step in eliminating membrane biofouling.
- FIG. 5 presents relative luminescence of membranes exposed to a solution of Pseudomonas aeruginosa for 1 h. High intensity indicates high bacterial adhesion. The plots show luminescence readings with background luminescence subtracted. Error bars are plus/minus 1 standard error (sample standard deviation divided by the square root of sample size).
- the enhanced hydrophilicity provided by polydopamine without introducing electrostatic charge to the membrane surface results, as expected, in decreased levels of bacterial adhesion to six of the seven tested membranes.
- the reduced adhesion at short times shown in this study should result in slower-growing biofilms at longer times.
- Polysulfone ultrafiltration Al support was provided by General Electric Water and was used as the UF membrane in FIG. 2 in this specification.
- Polysulfone UF (Sepro #: PS-20) and polyethersulfone UF (Sepro #: PES-30) membranes were also purchased from Sepro and used in all fouling studies ( FIGS. 4 and 5 ).
- Reverse osmosis polyamide membranes (XLE RO) and nanofiltration polyamide membranes (NF-90) were provided by Dow Water Solutions and served as the RO and NF membranes, respectively, described in the examples.
- Polypropylene (0.1 micron, GE catalog #: M01WP) and poly(tetrafluoroethylene) (0.22 micron, GE catalog #: F02LP) MF membranes were purchased from GE Water and Process Technologies.
- Poly(vinylidene fluoride) MF (0.22 micron, Millipore Cat. #: GVHP) membranes were purchased from Millipore Corp.
- Dopamine, Trizma (TRIS), decane, DTAB, bovine serum albumin and sodium hydroxide were purchased from Sigma Aldrich.
- NHS-rhodamine was purchased from Pierce Biotechnology.
- Ultrapure water (18.2 Mohm-cm, ⁇ 1 ppb TOC) was produced from a Gradient A10/RiOs Millipore water purification system.
- DC193 nonionic surfactant was purchased from Dow Corning.
- Wesson vegetable oil was purchased from a local supermarket.
- the sample was vortexed for 5 seconds.
- the solution was immediately placed in the casting ring.
- the solution was stirred using a rocker (e.g., 4 degrees and 50 rpm) or an orbital shaker.
- the solution gradually changed from slightly transparent red color to dark brown color during the course of the reaction.
- a visible, brown-colored deposition occurred on the membrane surface.
- the deposition color became darker as the deposition time increased.
- Membranes were then rinsed and stored in ultrapure water until their use.
- the present invention further describes three mechanisms for reducing biofouling: attachment of a hydrophilic molecule like PEG; attachment of bactericides like silver/copper ions to the polydopamine, and attachment of furanones to the membrane surface to reduce bacterial proliferation.
- the present invention focuses on tuning pertinent membrane surface properties by attaching long chain hydrophilic or hydrophobic polymers to the polydopamine deposition layer.
- the surface modifications combined with the polydopamine deposition on the surface will reduce fouling and partially soluble salt scaling and improve membrane fluxes.
- the crossflow filtration unit used to test oil fouling in NF and RO membranes was purchased from Separations Systems Technologies ( FIG. 6 , San Diego, Calif.). This apparatus was equipped with three filtration cells, each with an effective filtration area of 7.8 cm ⁇ 2.5 cm (19.4 cm 2 ) and a flow channel depth of 3.1 mm. The membranes were tested at a crossflow rate of 3.8 L/min and 10.2 atm transmembrane pressure. The permeate of each membrane was collected in a beaker placed on an electronic balance. The balances were connected to a computer and weight measurements were collected every 60 s by a Labview (National Instruments, Austin, Tex.) software program. Organic rejection was calculated using the following equation:
- C p is the organic concentration in the permeate
- C f is organic concentration in the feed.
- C p and C f were measured using a Total Organic Carbon Analyzer (TOC5050, Shimadzu Corp., Japan).
- Salt rejection was also measured using equation 1, with C p and C f being the salt concentrations of the permeate and feed, respectively (NaCl was added to the feed prior to fouling studies to make the total NaCl feed concentration 2000 ppm).
- the salt concentrations were measured using a conductivity meter (Oakton, Vernon Hills, Ill., USA).
- the system used in the NF and RO fouling employed a diaphragm pump (Wanner Hydra Cell, Minneapolis, Minn., USA) whose flow rate and pressure were unstable below approximately 3 atm. Therefore, to test UF and MF membranes at lower pressures, a similar system was built using a peristaltic pump (Cole Parmer, USA). The same cell used in the RO system was used in these experiments; however, the UF and MF system was equipped with only one test cell. The MF membranes were tested at a crossflow rate of 2.0 L/min and 0.3 atm (5 psi) transmembrane pressure.
- a diaphragm pump head was used on the peristaltic pump motor drive to achieve higher pressures with stable flow rates.
- the UF membranes were tested at 2.1 atm (30 psi) and 0.8 L/min crossflow rate. Permeate weight measurements were collected every 10 s for these experiments.
- a non-ionic oil/water emulsion was prepared by adding 40.5 grams of vegetable oil and 4.5 grams DC193 surfactant (9:1 oil:surfactant ratio) to water to make 3 kilograms of total solution.
- n-Decane/DTAB emulsions were prepared by adding 4.05 grams n-decane, 0.45 grams DTAB to water to make 3 kilograms of total solution. The mixtures were blended at 20,000 rpm for 3 minutes in a high-speed blender (Waring LBC15, Torrington, Conn.). The mixtures were diluted with pure water to make a total organic concentration of 1,500 ppm for the non-ionic oil/water emulsion or 150 ppm for the n-decane/DTAB emulsion.
- Irreversible oil fouling is determined by comparing the pure water permeance of a membrane before and after a fouling experiment.
- the pure water flux of a membrane was determined at the same pressure and crossflow rate that the fouling experiment took place (for example, at 2.1 atm and 0.8 L/min for a UF membrane).
- saltwater flux and rejection were determined immediately after the pure water flux (NaCl was added to the feed until the total feed concentration was 2000 ppm).
- a fouling experiment was then performed on the membranes (for the NF and RO membranes, the fouling experiment time was 24 h, for the UF and MF membranes, a 1 h fouling time was used).
- the crossflow system was flushed with ultrapure water at least three times, after which time water was allowed to circulate through the system (the rinsing cycle took a total of one hour to complete for the NF and RO membranes and 30 minutes for the UF and MF membranes).
- the post-fouling pure water flux was recorded after the rinsing cycle.
- Protein adhesion experiments were performed using a fluorimetric assay of tagged bovine serum albumin.
- R-NHS-tagged BSA was used to acquire data in this study, as polyamide membranes were found to have a large fluorescent intensity at approximately the same excitation/emission wavelengths as fluorescein.
- the fluorescent tagging of BSA was accomplished using a common approach 5 . Briefly, 40 mg BSA was dissolved in 5 mL of ultrapure water, and 8 mg R—NHS was dissolved in 175 ⁇ L of dimethyl sulfoxide. 150 ⁇ L of the R-NHS solution was added to the BSA solution and incubated at room temperature for 1 h, after which the reaction was quenched by adding 50 ⁇ L of glycine buffer.
- the reaction mixture was purified by eluting through sephadex columns and then dialysis against ultrapure water using Slide-A-Lyzers for 24-48 hours (Thermo Fisher Scientific, Inc. #66380, Rockford, Ill., USA).
- the final concentration and fluorescent tags per BSA molecule were analyzed using UV spectrophotometry 5 . There were approximately 3.5 rhodamine molecules per BSA molecule. 2.5 cm (1 in.) diameter samples were cut from flat-sheet membranes. The circular samples were placed in dead-end cells (Advantec MFS, #UHP 25, Dublin, Calif., USA) having an effective surface area of 3.5 cm 2 and washed several times with ultrapure water.
- R-NHS-tagged BSA solution (0.1 mg/mL in ultrapure water) was then added to the cells. After 1 h, the protein solutions were decanted and the membrane surface was washed gently three times with ultrapure water. The membranes were then air-dried and tested for fluorescent intensity using a plate reader (Tecan Sapphire II, Mannedorf, Switzerland).
- Bacterial adhesion to modified and unmodified membranes was performed using an assay of genetically-modified luminescent bacteria.
- a freezer stock of Pseudomonas aeruginosa (stored at ⁇ 80° C.) was provided by the Marvin Whiteley laboratory.
- the bacteria were genetically modified by the Whiteley lab from the PA14 strain of Pseudomonas aeruginosa containing the pQF50 parent plasmid. Plasmids are extra-chromosomal DNA molecules that are expressed by the cell. Plasmids, which occur naturally in bacteria, are also able to replicate independent of the chromosomal DNA.
- a lux operon (a sequence of five genes) of Photorabdus luminescens is responsible for the light-producing ability of this bacterium.
- the lux operon from P. luminescens was cloned into the pQF50 plasmid of P. aeruginosa to produce the pQF50-lux plasmid. This alteration allows Pseudomonas aeruginosa to luminesce.
- Cells are grown from the freezer stock in the presence of carbenicillin antibiotic.
- the pQF50-lux plasmid contains genes that give the bacteria resistance to the carbenicillin antibiotic. Light production is a very energy-intensive process.
- the cell will readily discard the plasmid to avoid the energetic requirements of such. However, if the same plasmid containing the lux operon also provides resistance to an antibiotic in the growth media, the cell will retain the plasmid, thus retaining its luminescent quality.
- Culture plates were prepared on LB agar (Miller formulation) that was dissolved in deionized water according to manufacturer instruction and autoclaved. Carbenicillin antibiotic was added to produce a mixture with a carbenicillin concentration of 100 ⁇ g/mL. This mixture was poured into sterile petri plates and cooled. The plates were stored at 4° C. Liquid LB media was also prepared according to manufacturer instruction and autoclaved. Again, enough carbenicillin was added to produce a mixture with a carbenicillin concentration of 100 ⁇ g/mL.
- Unmodified, PDOPA-modified, and PDOPA-g-PEG-modified 1′′-diameter membranes were loaded in dead-end cells.
- the bacteria suspension was dispensed into the dead-end cells (2 mL) and incubated at 37° C. for one hour. After one hour, the bacteria suspension was removed and the membranes were gently rinsed with about 10 mL deionized water.
- Four 1 ⁇ 4′′-diameter samples were cut out of each membrane and loaded into an opaque white 96-well plate. 100 ⁇ L fresh LB broth (no antibiotic) was dispensed into each cell to ensure that the bacteria would luminesce during the assay.
- Luminescence (with no filter) was measured in a BioTek Synergy HT plate reader (BioTek, Winooski, Vt.) running KC4 software. Luminescence of membrane samples with no bacteria was measured and any background was subtracted from the sample luminescence readings. High luminescence indicates high bacterial adhesion.
- dopamine is discussed here as a membrane modifying agent
- multiple embodiments using the functionalized chemistry seen in dopamine could lead to similar anti-biofilm formation membrane coatings.
- These key functionalities are the catechol-like dihydroxy phenyl group and the amine group, which have been identified in the literature as key elements in a mussel's adhesive plaque. Therefore molecules, or multiple molecules, whose substituents include aromatic dihydroxy groups and amine groups, could be used to modify membrane surfaces.
- thiol groups have also been shown to react with the catechol-like dihydroxy phenyl group. Therefore, any thiol containing molecule could also be combined with any aromatic dihydroxy group-containing molecule to form a membrane modifying agent.
- dopamine or other aromatic dihydroxy and amine-containing molecules could be copolymerized with a variety of different molecules containing aromatic dihydroxy, amine, or thiol functionality. These new polymers can also be used to modify membrane surfaces.
- FIG. 7 illustrates an image and schematic of a laboratory-scale crossflow system.
- FIG. 6 illustrates a crossflow system 10 having a feed tank 12 connected to membrane cells or modules 14 a , 14 b and 14 c .
- the crossflow system 10 may also include a flow meter 16 , pressure gauge 18 , thermometer 20 and balances 22 a , 22 b and 22 c .
- a crossflow system schematic 24 it can be seen that the feed tank 12 is kept at a constant temperature and connected to a pump 26 that is connected to a bypass 28 , a flow-meter 30 and pressure gauge 32 .
- the pressure gauge 32 is connected to one or more membrane cells 14 a , 14 b and 14 c .
- membrane cells/modules 14 there are 3 membrane cells/modules illustrated here, the skilled artisan will recognize that this is for simplicity's sake only and the present invention may include numerous membrane cells/modules 14 .
- One or more membrane cells 14 a , 14 b and 14 c allow some of the substance to pass through and be collected 34 a , 34 b and 34 c .
- a temperature gauge 36 and a may be fitted to the system.
- the feed water in the feed tank 12 is pumped through a series of membrane cells 14 at high transmembrane pressure. A portion of the feed water contacts the membrane surface 40 and allows pure water to pass through the membrane 40 and collected 34 , while rejecting contaminants. The portion of the feed water that does not pass through the membrane 40 is returned to the feed tank 12 for future filtration.
- modified crossflow system 42 includes a feed tank 12 which contains a dopamine solution 44 and is connected to a pump 26 that is connected to a bypass 28 , and a flow-meter 30 .
- modified crossflow system 42 may include a filter 46 positioned before membrane cells 14 and membrane module 40 .
- the modified crossflow system 42 may also be connected to a pressure gauge 32 , temperature gauge 36 and/or a pressure regulator 48 in any order or combination necessary.
- the present invention may include “n” number distributions of a filter 46 positioned before membrane cells 14 . “n” may be 1, 2, 3, 4, 5, 6, 7, 8, 9, 10-100, or more than 100 repeats.
- the dopamine solution 44 in the feed tank 12 is pumped using pump 26 through a series of one or more membrane cells/modules 14 at low or high transmembrane pressure.
- the dopamine solution 44 passes in contact with the membrane surface 40 and allows the dopamine solution 44 to be deposited on the membrane 40 .
- the remaining dopamine solution 44 is returned to the feed tank 12 .
- One advantage of the present invention is the ease of application of the polydopamine to the membrane surfaces of small and large-scale membrane modules.
- the approach further allows modification of all wetted membrane module parts regardless of the membrane material.
- Polydopamine permits the tuning of membrane surface properties for specific applications.
- a library of compounds is available to covalently attach to the polydopamine layer.
- the polydopamine deposition method is advantageous over other modifications, because of the non-specific adherence of polydopamine to the membrane surface and modification of all wetted parts of the membrane module.
- the deposition of polydopamine is achieved by dissolving it in a slightly alkaline water solution (pH 8-10) and circulating the dopamine solution through a menbrane module housing for an extended period of time from about 1 minute to 24 hours, e.g., about 60 minutes.
- a slightly alkaline water solution pH 8-10
- circulating the dopamine solution through a menbrane module housing for an extended period of time from about 1 minute to 24 hours, e.g., about 60 minutes.
- the deposition time of polydopamine can be reduced or optimized by chemical techniques, or by altering the solution pH and dopamine concentration.
- dopamine is discussed here as a membrane modifying agent, composition and additive, the functionalized chemistry lead to coatings and compositions that reduce biofilm formation.
- These key functionalities are the catechol-like dihydroxy phenyl group and the amine group, which have been identified in the literature as key elements in a mussel's adhesive plaque. Therefore molecules, or multiple molecules, whose substituents include aromatic dihydroxy groups and amine groups, could be used to modify membrane surfaces.
- thiol groups have also been shown to react with the catechol-like dihydroxy phenyl group. Therefore, any thiol-containing molecule could also be combined with any aromatic dihydroxy group-containing molecule to form a membrane modifying agent.
- dopamine or other aromatic dihydroxy and amine-containing molecules could be copolymerized with a variety of different molecules containing aromatic dihydroxy, amine, or thiol functionality. These new polymers can also be used to modify membrane surfaces.
- the polydopamine treatments and compositions of the present invention have an advantage over other conventional surface modification techniques in that the surface modification can be performed on the membranes after they have been processed into module form.
- the present invention provides methods and compositions for the modification of conventional water purification membranes purchased in spiral-wound modules, hollow fiber modules, flat sheets or other preformed structures (as described elsewhere to the artisan).
- a slightly modified water purification crossflow system can be used, or the membranes can be modified in-place in a large scale water purification plant.
- the present invention provides polydopamine treatments for membrane surfaces that have been processed into module forms.
- a standard purification system one such crossflow system is described above
- the permeate side of the membrane module 40 can be initially blocked to eliminate the dopamine solution 44 from being transmitted through the membrane 40 .
- a rubber stopper or a clamp (or other device known to the skilled artisan) (not shown) can be used to block the membrane 40 and is removed after the dopamine treatment.
- the dopamine solution can also be allowed to permeate through the membrane if so chosen by the artisan by not blocking the permeate during the modification process.
- an alkaline dopamine solution 44 forms microparticles (not shown) that can impede water flow through the feed-side of membrane modules 40 and therefore could be removed if deemed problematic by the artisan from the feed stream.
- a particle filter 46 can be placed in-line near the inlet of each membrane module 40 to remove microparticles (not shown) that form during the polydopamine formation.
- a particle filter 46 may be placed further up-line before the distribution to the inlet of each membrane cell 14 .
- filters 46 or series of filters may be used to accomplish filtration prior to the inlet of each membrane module 14 . Therefore, these particles can be removed before the dopamine solution 44 is introduced into the membrane module 14 .
- the particle filter 46 nominal pore diameter may be in between 0.05 microns and 200 microns, with a preferable nominal pore diameter of approximately 5 microns.
- the particle filter 46 nominal pore diameter need only be sufficient to filter the particles and may use a series of filters 46 with different pore diameters.
- a small pump 26 can be used in place of the high-powered pump to achieve lower transmembrane pressures.
- the pump 26 should be capable of operating at low pressures (e.g., 0-500 psig, with a preferable pressure range in between 0-10 psig) and flowrates that keep the residence time of the dopamine solution 44 in each membrane cell 14 between 0.0 seconds and 3 hours, with a preferable residence time between 0.0 seconds and 10 minutes.
- the small residence time ensures that little microparticle formation is observed in the membrane cell/module 14 . Residence time is defined as the total feed-side volume of a membrane cell 14 divided by the volumetric flow rate of the feed-side dopamine solution 44 .
- the polymers may be made into a membrane for separations, films, sheets, tubes, rolls, hollow filaments, or fibers objects of a specific shape.
- polymers having a porous separation membrane, or substrate, and a coating in occluding contact with the porous separation membrane are also contemplated.
- the present invention also provides a method, apparatus and modified crossflow system 42 for the treatment of numerous modules in series.
- membrane cells/modules 14 can be added to the modified crossflow system in series, numerous membrane cells/modules 14 (e.g., from 0-100,000,000) can be polydopamine-treated at once.
- the modified crossflow system can include any number of membrane modules (e.g., 1-10, 10's, 100's, 1000's, 10,000's, 100,000's to more than 100,000,000 membrane modules) connected in series or parallel, series of modules.
- membrane modules can be modified by simply adding an alkaline dopamine solution to either the feed side, permeate side, or both and subsequently sealing the membrane module and mixing by agitating the module (i.e. rolling, shaking, etc.).
- Membrane modules may also be modified by use of a clean-in-place (CIP) system.
- CIP systems permit cleaning of the membrane with pure water or with chemical cleaner in either forward or reverse directions without having to disconnect the membrane module.
- Typical CIP systems include a pure water or chemical storage/mixing tank and a pump attached to the feed side, permeate side, reject side, or some combination therein.
- a dopamine solution as described previously, may be placed in the storage/mixing tank and pumped into the membrane module for modification.
- the membrane being modified may be in part or entirely made of one or more polymers.
- the polymer surface may include Polyethylene (PE); Polypropylene (PP); Polystyrene (PS); Polyethylene terephthalate (PET or PETE); Polyamide (PA); Polysulfone; sulfonated polysulfone or any other polyelectrolyte that is suitable for membrane use; Polyester, Polyvinyl chloride (PVC); Polycarbonate (PC); Acrylonitrile butadiene styrene (ABS); Polyvinylidene chloride (PVDC); Polytetrafluoroethylene (PTFE); Polymethyl methacrylate (PMMA); Polylactic acid (PLA), Polypiperazine, and combinations thereof.
- PE Polyethylene
- PP Polypropylene
- PS Polystyrene
- PET or PETE PETE
- PETE PETE
- PA Polyamide
- Polysulfone Polysulfonated polysulfone or any other polyelectrol
- PE Polyethylene
- PP Polypropylene
- PS Polystyrene
- PETE Polyethylene terephthalate
- PA Polyamide
- PVC Polyvinyl chloride
- PC Polycarbonate
- ABS Acrylonitrile butadiene styrene
- PVDC Polyvinylidene chloride
- PTFE Polytetrafluoroethylene
- PMMA Polymethyl methacrylate
- PVA Polylactic acid
- the polymer may be made from one or more monomers selected from: methyl acrylate, ethyl acrylate, propyl acrylate (all isomers), butyl acrylate (all isomers), 2-ethylhexyl acrylate, isobornyl acrylate, acrylic acid, benzyl acrylate, phenyl acrylate, acrylonitrile, glycidyl acrylate, 2-hydroxyethyl acrylate, hydroxypropyl acrylate (all isomers), hydroxybutyl acrylate (all isomers), diethylaminoethyl acrylate, triethyleneglycol acrylate, N-tert-butyl acrylamide, N-n-butyl acrylamide, N-methyl-ol acrylamide, N-ethyl-ol acrylamide, trimethoxysilylpropyl acrylate, triethoxysilylpropyl acrylate, tributoxysily
- the polymer may be inpart or entirely made from poly(1-phenyl-2-[p-trimethylsilylphenyl]acetylene, poly(1-trimethylsilyl-1-propyne), poly(ethylene octene), crosslinked poly(ethylene oxide), and 1,2-polybutadiene.
- the polymers of the present invention may be modified and/or substituted with one or more halogens, hydroxyl groups, lower alkyl groups, lower alkoxy groups, monocyclic aryl, lower acyl groups and combinations thereof.
- one or more functional groups for the polymer may be chosen from ROOH, ROSH, RSSH, OH, SO 3 H, SO 3 R, SO 4 R, COOH, NH 2 , NHR, NR 2 , CONH 2 , and NH—NH 2 , wherein R denotes, e.g., linear or branched hydrocarbon-based chains, capable of forming at least one carbon-based ring, being saturated or unsaturated; alkylenes, siloxanes, silanes, ethers, polyethers, thioethers, silylenes, and silazanes.
- the polymers may include rubbery polymers, stiff chain polymers, glassy polymers and combinations thereof including: poly(1-phenyl-2-[p-trimethylsilylphenyl]acetylene (hereafter referred to as “PTMSDPA”) and poly(1-trimethylsilyl-1-propyne) (hereafter referred to as “PTMSP”) and elastomeric and rubbery polymers including poly(ethylene octene).
- PTMSDPA poly(1-phenyl-2-[p-trimethylsilylphenyl]acetylene
- PTMSP poly(1-trimethylsilyl-1-propyne)
- elastomeric and rubbery polymers including poly(ethylene octene).
- polymers suitable for the present invention can be substituted or unsubstituted polymers and may include polysulfone, copolymer of styrene and acrylonitrile poly(arylene oxide), polycarbonate, and cellulose acetate, polysulfones; poly(styrenes), including styrene-containing copolymers such as acrylonitrilestyrene copolymers, styrene-butadiene copolymers and styrene-vinylbenzylhalide copolymers; polycarbonates; cellulosic polymers, such as cellulose acetate-butyrate, cellulose propionate, ethyl cellulose, methyl cellulose, nitrocellulose, etc.; polyamides and polyimides, including aryl polyamides and aryl polyimides; polyethers; poly(arylene oxides) such as poly(phenylene oxide) and poly(xylene oxide); poly(esteramide-diis
- the present invention includes the use of phenethylamine and modified and substituted phenethylamine monomers.
- the present invention provides the polymerization of various monomers, polymers and/or co-monomer combinations.
- monomers may include a single monomer or a combination of 2 or more monomers including phenethylamine, 3-trifluoromethylphenethylamine, 2-chlorophenethylamine, 3-chlorophenethylamine, 4-chlorophenethylamine, 2,4-dichlorophenethylamine, 3-bromophenethylamine, 4-iodophenethylamine, 3-hydroxyphenethylamine, 4-hydroxyphenethylamine, 2,4-dihydroxyphenethylamine, 2-methylphenethylamine, 3-methylphenethylamine, 4-methylphenethylamine, 2,4-dimethylphenethylamine, 2,4,6-trimethylphenethylamine, 3-
- ⁇ -Phenylethylamine (2-Phenylethylamine), Phenethylamine, 4-hydroxy-phenethylamine, 3,4-dihydroxy-phenethylamine, ⁇ ,3,4-trihydroxy-N-methylphenethylamine, ⁇ ,3,4-trihydroxyphenethylamine, ⁇ ,3-dihydroxy-N-methylphenethylamine, 2,4,5-trihydroxyphenethylamine, ⁇ ,4-dihydroxy-3-hydroxymethyl-N-tert-butyl-phenethylamine, ⁇ -methyl-3-acetylphenethylamine, ⁇ -ketoamphetamine, N-methyl- ⁇ -ketoamphetamine, 3-chloro-N-tert-butyl- ⁇ -ketoamphetamine, 3-trifluoromethyl-N-ethyl-amphetamine, 3,4,5-trimethoxyphenethylamine, 3,4-methylenedioxyamp
- Tyramine Dopamine, Epinephrine (Adrenaline), norepinephrine (Noradrenaline), Phenylephrine, 6-Hydroxydopamine, Salbutamol, Acetylamphetamine, Cathinone, Methcathinone, Bupropion, Fenfluramine, Mescaline, MDA, MDMA, MDMC, DOM, DOB, DON, 2C-B, 2C-C, DOI, 2C-I, 2C-D, 2C-E, 2C-F, 2C-N, 2C-T-2, 2C-T-4, 2C-T-7, 2C-T-8, 2C-T-9, and 2C-T-21.
- the material of the present invention can be subjected to extrusion, injection molding, hot pressing, coating, painting, laminating, and solvent casting, mixtures and combinations thereof and formed into a bead, a film, a tube, a sheet, a thread, a suture, a gauze, a bandage, an adhesive bandage, a vessel, a container, a cistern, a filter, a membrane, a coating, a paint and combinations thereof.
- the polymers, monomers or copolymer may be modified by the addition or substitution of one or more of the following groups: lower alkyl, alkenyl, amino, aryl, alkylaryl, halogen, halo, haloalkyl, phosphoryl or combination thereof.
- the modification may be similarly modified with one or more lower alkyl, alkenyl, amino, aryl, alkylaryl, halogen, halo, haloalkyl, phosphoryl or combination thereof.
- the polymers, monomers or copolymer may include monomers that are hydrophilic and/or hydrophobic and may be cross-linked to form polymer films and/or membranes.
- the polymers can have very high concentrations of ionic groups (i.e., sulfonic acid) without a high water uptake.
- the present invention may include sulfonated polymer structures and substrates. For example, current sulfonated polymer membranes for reverse osmosis applications display stability over a pH range of about 4 to about 11, with a high water flux and high chlorine tolerance.
- the polymers may be made into a membrane for separations, films, sheets, tubes, rolls, hollow filaments, or fibers objects of a specific shape.
- polymers having a porous separation membrane, or substrate, and a coating in occluding contact with the porous separation membrane are also contemplated.
- compositions of the invention can be used to achieve methods of the invention.
- the present invention may be made mixed with a material prior, during or after material or article formation and provide anti-biofilm, thermal and photo stabilizing function.
- the material of the present invention can be subjected to extrusion, injection molding, hot pressing, coating, painting, laminating, and solvent casting, mixtures and combinations thereof and formed into a bead, a film, a tube, a sheet, a thread, a suture, a gauze, a bandage, an adhesive bandage, a vessel, a container, a cistern, a filter, a membrane, a coating, a paint and combinations thereof.
- the present invention aims to reduce fouling, scaling, and biofilm formation in conventional polymeric membranes by a novel technique of polymer deposition.
- the invention describes polydopamine, which is highly hydrophilic and can be deposited onto virtually any surface with which it comes into contact. Polydopamine adheres strongly to the surface, and can covalently link to properly conjugated molecules thereby reducing biofilm formation. Furthermore, polydopamine can react with metal ions, thereby forming metallic particles on the membrane surface via an electronless metallization mechanism.
- Polydopamine is a hydrophilic polymer and can deposit on virtually any surface with which it comes into contact. Thus, it can be used as an effective anti-fouling/scaling coating layer in many membrane water purification applications, including wastewater treatment, beverage clarification, oil and natural gas produced water treatment, and desalination. Furthermore, polydopamine's reactive functionalities provide an effective means to graft other non-fouling/scaling molecules on membrane surfaces.
- compositions of the invention can be used to achieve methods of the invention.
- A, B, C, or combinations thereof refers to all permutations and combinations of the listed items preceding the term.
- “A, B, C, or combinations thereof” is intended to include at least one of: A, B, C, AB, AC, BC, or ABC, and if order is important in a particular context, also BA, CA, CB, CBA, BCA, ACB, BAC, or CAB.
- expressly included are combinations that contain repeats of one or more item or term, such as BB, AAA, MB, BBC, AAABCCCC, CBBAAA, CABABB, and so forth.
- BB BB
- AAA AAA
- MB BBC
- AAABCCCCCC CBBAAA
- CABABB CABABB
- compositions and/or methods disclosed and claimed herein can be made and executed without undue experimentation in light of the present disclosure. While the compositions and methods of this invention have been described in terms of preferred embodiments, it will be apparent to those of skill in the art that variations may be applied to the compositions and/or methods and in the steps or in the sequence of steps of the method described herein without departing from the concept, spirit and scope of the invention. All such similar substitutes and modifications apparent to those skilled in the art are deemed to be within the spirit, scope and concept of the invention as defined by the appended claims.
Landscapes
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Manufacturing & Machinery (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/500,364 US20100059433A1 (en) | 2008-07-10 | 2009-07-09 | Polymer deposition and modification of membranes for fouling resistance |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7960808P | 2008-07-10 | 2008-07-10 | |
US12/500,364 US20100059433A1 (en) | 2008-07-10 | 2009-07-09 | Polymer deposition and modification of membranes for fouling resistance |
Publications (1)
Publication Number | Publication Date |
---|---|
US20100059433A1 true US20100059433A1 (en) | 2010-03-11 |
Family
ID=41507744
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/500,364 Abandoned US20100059433A1 (en) | 2008-07-10 | 2009-07-09 | Polymer deposition and modification of membranes for fouling resistance |
US12/500,514 Active 2029-10-08 US8017050B2 (en) | 2008-07-10 | 2009-07-09 | Water purification membranes with improved fouling resistance |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/500,514 Active 2029-10-08 US8017050B2 (en) | 2008-07-10 | 2009-07-09 | Water purification membranes with improved fouling resistance |
Country Status (12)
Country | Link |
---|---|
US (2) | US20100059433A1 (ja) |
EP (1) | EP2318126B1 (ja) |
JP (1) | JP5463355B2 (ja) |
KR (1) | KR101310054B1 (ja) |
CN (1) | CN102149450A (ja) |
AU (1) | AU2009268532B2 (ja) |
BR (1) | BRPI0915547A2 (ja) |
CA (1) | CA2767761C (ja) |
IL (1) | IL210488A (ja) |
MX (1) | MX2011000218A (ja) |
WO (1) | WO2010006196A2 (ja) |
ZA (1) | ZA201101059B (ja) |
Cited By (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012009720A1 (en) * | 2010-07-16 | 2012-01-19 | University Of Connecticut | Method of modifying thin film composite membrane support structures for engineered osmosis applications |
US20120080378A1 (en) * | 2010-09-30 | 2012-04-05 | Ravindra Revanur | Thin film composite membranes for forward osmosis, and their preparation methods |
WO2012158717A2 (en) * | 2011-05-16 | 2012-11-22 | Advanced Hydro Inc | Improved membranes with polydopamine coatings |
KR101327891B1 (ko) | 2012-02-02 | 2013-11-11 | 에스케이씨 주식회사 | 생체고분자로 코팅된 다공성 필름 및 이를 포함하는 이차전지용 분리막 |
CN103394295A (zh) * | 2013-08-14 | 2013-11-20 | 哈尔滨工业大学 | 一种亲水性pvdf复合超滤膜及其制备方法 |
CN103717978A (zh) * | 2011-08-02 | 2014-04-09 | 株式会社电装 | 空调系统 |
US20150176852A1 (en) * | 2012-11-30 | 2015-06-25 | C'stec Corporation | Wall, system of highly clean rooms, production method thereof and construction |
US9216391B2 (en) | 2011-03-25 | 2015-12-22 | Porifera, Inc. | Membranes having aligned 1-D nanoparticles in a matrix layer for improved fluid separation |
US9221019B2 (en) | 2011-05-27 | 2015-12-29 | Samsung Electronics Co., Ltd. | Organic/inorganic hybrid compound for fouling resistance, membrane including the same for fouling resistance, and method of preparing membrane for fouling resistance |
US20150375181A1 (en) * | 2014-06-30 | 2015-12-31 | Pall Corporation | Fluorinated polymer and use thereof in the preparation of hydrophilic membranes (vi) |
US9227360B2 (en) | 2011-10-17 | 2016-01-05 | Porifera, Inc. | Preparation of aligned nanotube membranes for water and gas separation applications |
WO2016178935A1 (en) | 2015-05-01 | 2016-11-10 | Teledyne Scientific & Imaging, Llc | Coated granular filtration media |
US9636635B2 (en) | 2012-12-21 | 2017-05-02 | Porifera, Inc. | Separation systems, elements, and methods for separation utilizing stacked membranes and spacers |
US9861937B2 (en) | 2013-03-15 | 2018-01-09 | Porifera, Inc. | Advancements in osmotically driven membrane systems including low pressure control |
WO2018013587A1 (en) * | 2016-07-11 | 2018-01-18 | The Arizona Board Of Regents On Behalf Of The University Of Arizona | Polymeric sunscreen materials |
WO2018044675A1 (en) * | 2016-08-29 | 2018-03-08 | The Penn State Research Foundation | Membrane surface activation to eliminate fouling and concentration polarization in water purification systems |
JP2018173306A (ja) * | 2017-03-31 | 2018-11-08 | 日立化成株式会社 | 分離材及びカラム |
US10220355B2 (en) | 2013-12-09 | 2019-03-05 | Samsung Electronics Co., Ltd. | Compound for fouling resistance, membrane for fouling resistance, and method of preparing membrane for fouling resistance |
US10239021B2 (en) | 2012-06-14 | 2019-03-26 | Teledyne Scientific & Imaging, Llc | Fouling resistant coating for filtration membranes and methods of producing and using same |
KR20190042302A (ko) | 2017-10-16 | 2019-04-24 | 한국과학기술연구원 | 질화 붕소 나노 물질을 이용한 가열 재생 가능한 한외여과막과 그 제조 및 재생 방법 |
US10384169B2 (en) | 2014-10-31 | 2019-08-20 | Porifera, Inc. | Supported carbon nanotube membranes and their preparation methods |
US20210054172A1 (en) * | 2019-08-20 | 2021-02-25 | B. J. Zh. F. Panther Medical Equipment Co., Ltd. | Polydopamine film and preparation method and application thereof |
CN112778564A (zh) * | 2021-01-06 | 2021-05-11 | 吉林大学 | 碳纤维增强聚醚醚酮复合材料及生物活性改善方法和应用 |
WO2021222266A1 (en) * | 2020-04-27 | 2021-11-04 | The Trustees Of Princeton University | Solar-powered water purification and decontamination gel compositions |
US11389386B2 (en) | 2016-01-29 | 2022-07-19 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Photochemically stable, non-leaching, bridged polysilsesquioxane based sunscreens |
US11452291B2 (en) | 2007-05-14 | 2022-09-27 | The Research Foundation for the State University | Induction of a physiological dispersion response in bacterial cells in a biofilm |
US11541352B2 (en) | 2016-12-23 | 2023-01-03 | Porifera, Inc. | Removing components of alcoholic solutions via forward osmosis and related systems |
US11541105B2 (en) | 2018-06-01 | 2023-01-03 | The Research Foundation For The State University Of New York | Compositions and methods for disrupting biofilm formation and maintenance |
US11571660B2 (en) | 2015-06-24 | 2023-02-07 | Porifera, Inc. | Methods of dewatering of alcoholic solutions via forward osmosis and related systems |
EP4201508A1 (en) | 2021-12-21 | 2023-06-28 | Gambro Lundia AB | Membrane coated with polydopamine and chondroitin and process for producing same |
EP4201507A1 (en) | 2021-12-21 | 2023-06-28 | Gambro Lundia AB | Method for increasing the selectivity of a membrane |
US12005396B2 (en) | 2019-11-14 | 2024-06-11 | Porifera, Inc. | Advancements in osmotically driven membrane systems including multi-stage purification |
Families Citing this family (102)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8177978B2 (en) | 2008-04-15 | 2012-05-15 | Nanoh20, Inc. | Reverse osmosis membranes |
US20100059433A1 (en) * | 2008-07-10 | 2010-03-11 | Board Of Regents, The University Of Texas System | Polymer deposition and modification of membranes for fouling resistance |
WO2011143371A1 (en) * | 2010-05-11 | 2011-11-17 | The Regents Of The University Of California | Oil-tolerant polymer membranes for oil-water separations |
CN101913278B (zh) * | 2010-06-30 | 2013-07-24 | 中国科学技术大学 | 用于毛细管电泳分离蛋白质的聚多巴胺-g-聚环氧乙烷毛细管涂层的制备方法 |
CN102397756A (zh) * | 2010-09-08 | 2012-04-04 | 天津工业大学 | 一种疏水性分离膜处理方法 |
US8752714B2 (en) | 2011-03-01 | 2014-06-17 | Dow Global Technologies Llc | Sulfonated poly (aryl ether) membrane including blend with phenyl amine compound |
US8829060B2 (en) | 2011-03-01 | 2014-09-09 | Dow Global Technologies Llc | Sulfonated poly(aryl ether) membrane including blend with phenol compound |
KR101308913B1 (ko) | 2011-04-06 | 2013-09-23 | 한국과학기술원 | 폴리도파민을 이용한 폐수 정제 방법 |
US8828235B2 (en) | 2011-08-22 | 2014-09-09 | Monmouth University | Method for removing contaminants from water using thiol-modified surfaces containing ester linkages |
KR101303285B1 (ko) * | 2011-09-08 | 2013-09-04 | 한국기계연구원 | 환원된 산화 그래핀층 및 코팅층이 순차적으로 적층되는 그래핀 페이퍼 및 이의 제조방법 |
KR101340022B1 (ko) * | 2011-09-20 | 2013-12-10 | 한국과학기술원 | 폴리도파민 고속 코팅방법 |
KR101938009B1 (ko) * | 2012-05-31 | 2019-01-11 | 한양대학교 산학협력단 | 소수성 분리막의 개질 방법 및 개질 시스템 |
CN102706856B (zh) * | 2012-06-28 | 2014-05-07 | 福州大学 | 一种增强拉曼纳米粒子及其制备方法 |
JP6546094B2 (ja) * | 2012-10-12 | 2019-07-17 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | ポリアニリン膜ならびにその用途および方法 |
CN102908903A (zh) * | 2012-11-02 | 2013-02-06 | 东华大学 | 一种利用生物制剂进行中空纤维膜表面亲水改性的方法 |
CN102974238B (zh) * | 2012-11-02 | 2014-08-13 | 东华大学 | 一种利用生物制剂进行pva接枝的膜表面亲水改性方法 |
WO2014069786A1 (ko) * | 2012-11-05 | 2014-05-08 | 주식회사 엘지화학 | 내오염성이 우수한 폴리아미드계 수처리 분리막 및 그 제조 방법 |
CN103170258A (zh) * | 2012-12-04 | 2013-06-26 | 天津大学 | 聚二甲基硅氧烷/聚多巴胺杂化膜及制备方法 |
WO2014116812A2 (en) | 2013-01-24 | 2014-07-31 | Northwestern University | Phenolic coatings and methods of making and using same |
US9272075B2 (en) | 2013-02-04 | 2016-03-01 | W.L. Gore & Associates, Inc. | Coating for substrate |
EP2950832B1 (en) | 2013-02-04 | 2018-08-01 | W. L. Gore & Associates, Inc. | Coating for substrate |
JP6502861B2 (ja) * | 2013-02-21 | 2019-04-17 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 汎用拡張性高費用効率表面修飾 |
US9447304B2 (en) | 2013-03-14 | 2016-09-20 | W. L. Gore & Associates, Inc. | Coating for a surface |
US9533262B2 (en) | 2013-03-14 | 2017-01-03 | Dow Global Technologies Llc | Composite polyamide membrane including dissolvable polymer coating |
CN105451866B (zh) | 2013-05-15 | 2019-04-09 | 加州大学评议会 | 用于正向渗透应用的通过相反转形成的聚苯胺膜 |
CN103272496A (zh) * | 2013-06-22 | 2013-09-04 | 南昌航空大学 | 一种亲水性聚偏氟乙烯平板膜的制备方法 |
CN103418250B (zh) * | 2013-07-05 | 2015-12-02 | 烟台绿水赋膜材料有限公司 | 一种在分离膜表面原位生成纳米粒子的方法 |
CN104415670B (zh) * | 2013-08-23 | 2017-02-22 | 中国科学院宁波材料技术与工程研究所 | 一种金属有机框架膜及其制备方法和应用 |
KR102080283B1 (ko) * | 2013-10-04 | 2020-02-21 | 주식회사 엘지화학 | 표면개질 분리막 및 분리막의 표면개질 방법 |
KR101516614B1 (ko) * | 2013-11-04 | 2015-04-30 | 한국에너지기술연구원 | 나노섬유 복합 분리막 및 이의 제조방법 |
CN103613780B (zh) * | 2013-11-14 | 2015-09-30 | 中国科学院化学研究所 | 疏水性聚合物微孔膜的表面改性方法 |
KR102172281B1 (ko) * | 2013-12-27 | 2020-10-30 | 도레이첨단소재 주식회사 | 층간접착력이 우수한 정삼투막 및 그 제조방법 |
US20160325239A1 (en) | 2014-01-31 | 2016-11-10 | Dow Global Technologies Llc | Composite polyamide membrane including cellulose-based quaternary ammonium coating |
CN103866492A (zh) * | 2014-03-31 | 2014-06-18 | 北京服装学院 | 一种高效油水分离复合纤维膜及其制备方法 |
RU2717512C2 (ru) | 2014-04-08 | 2020-03-23 | Дзе Риджентс Оф Дзе Юниверсити Оф Калифорния | Устойчивые к хлору гидрофильные фильтрационные мембраны на основе полианилина |
CN105268328B (zh) * | 2014-07-14 | 2017-12-29 | 中国科学院宁波材料技术与工程研究所 | 一种通过模拟生物蛋白多巴胺功能化修饰制备分子筛膜的方法 |
CN105435645B (zh) * | 2014-07-22 | 2017-09-29 | 中国石油化工股份有限公司 | 一种复合纳滤膜及其制备方法 |
KR101626594B1 (ko) * | 2014-08-29 | 2016-06-02 | 도레이케미칼 주식회사 | 수처리용 섬유상 아라미드 여재 및 이의 제조방법 |
CN104368244B (zh) * | 2014-09-24 | 2017-01-25 | 浙江大学 | 一种儿茶酚化合物纳米粒子改性的聚合物复合膜的制备方法 |
US10023481B2 (en) | 2014-10-17 | 2018-07-17 | Clemson University | Materials and methods for reducing biofouling in water treatment membrane systems |
CN104436760B (zh) * | 2014-10-27 | 2016-08-24 | 北京服装学院 | 一种磁响应高效油水分离纤维膜及其制备方法 |
KR20160058579A (ko) * | 2014-11-17 | 2016-05-25 | 주식회사 아모그린텍 | 기능성 멤브레인 및 그의 제조 방법 |
CN105670565A (zh) * | 2014-11-18 | 2016-06-15 | 中国科学院兰州化学物理研究所 | 一种具有自修复功能的自清洁材料及其制备方法 |
CN104474925A (zh) * | 2014-12-12 | 2015-04-01 | 杭州水处理技术研究开发中心有限公司 | 一种高水通量聚酰胺反渗透复合膜的制备方法 |
US11459434B2 (en) | 2015-05-26 | 2022-10-04 | The University Of British Columbia | Antifouling polymeric coating compositions |
CN104898189B (zh) * | 2015-06-11 | 2016-05-25 | 丹阳市精通眼镜技术创新服务中心有限公司 | 采用多巴胺作为表面粘接层的防雾镜片及其工艺方法 |
JP2017018910A (ja) * | 2015-07-13 | 2017-01-26 | CO2M‐Tech株式会社 | 複合膜及びその製造方法 |
US9861940B2 (en) | 2015-08-31 | 2018-01-09 | Lg Baboh2O, Inc. | Additives for salt rejection enhancement of a membrane |
CN105597558B (zh) * | 2015-09-29 | 2018-11-13 | 浙江理工大学 | 一种具有催化降解功能的复合纳滤膜及其制备方法、应用 |
MY187365A (en) | 2015-11-06 | 2021-09-22 | Dow Global Technologies Llc | Filtration and reuse of surfactant-containing produced water for oil recovery |
CN105568556B (zh) * | 2015-12-15 | 2019-03-29 | 上海洁晟环保科技有限公司 | 超疏水或超亲水且具备抗菌性能的纳米纤维膜的制备方法 |
CN105597564B (zh) * | 2016-01-07 | 2018-12-11 | 浙江理工大学 | 一种金属酞菁接枝改性pvdf中空纤维膜的制备方法 |
US9737859B2 (en) | 2016-01-11 | 2017-08-22 | Lg Nanoh2O, Inc. | Process for improved water flux through a TFC membrane |
US10155203B2 (en) | 2016-03-03 | 2018-12-18 | Lg Nanoh2O, Inc. | Methods of enhancing water flux of a TFC membrane using oxidizing and reducing agents |
CN105749760A (zh) * | 2016-03-17 | 2016-07-13 | 哈尔滨工业大学宜兴环保研究院 | 一种油单通道高分子膜的制备方法 |
CN107478790A (zh) * | 2016-06-08 | 2017-12-15 | 中国石油化工股份有限公司 | 表面附有聚多巴胺亲水层的聚氨酯载体及其制备方法与应用 |
CN106076283B (zh) * | 2016-06-11 | 2018-09-14 | 华南理工大学 | 一种纳米纤维素/聚多巴胺水凝胶吸附剂及其制备方法与应用 |
CN109789377B (zh) * | 2016-08-08 | 2022-03-08 | 港大科桥有限公司 | 具有高生产量和水消毒性能的手提式重力驱动的水过滤器的制备 |
CN106731883B (zh) * | 2016-11-10 | 2019-12-10 | 北京林业大学 | 一种聚多巴胺纳米木质纤维素聚偏氟乙烯复合超滤膜及其制备方法 |
KR102500328B1 (ko) | 2016-12-01 | 2023-02-14 | 더 리전트 오브 더 유니버시티 오브 캘리포니아 | 에너지 제공 장치 및 그 응용 |
CN106757789B (zh) * | 2017-01-11 | 2019-01-08 | 西南交通大学 | 一种超亲水聚偏二氟乙烯/聚多巴胺复合薄膜的制备方法 |
CN106823831A (zh) * | 2017-03-03 | 2017-06-13 | 哈尔滨工业大学 | 一种有机催化膜的制备方法及应用 |
CN115137880B (zh) | 2017-04-13 | 2024-05-03 | 业聚医疗私人有限公司 | 一种具有涂层的医疗设备 |
US10646829B2 (en) | 2017-06-22 | 2020-05-12 | Teledyne Scientific & Imaging, Llc | High flux, chlorine resistant coating for sulfate removal membranes |
CN109304089B (zh) * | 2017-07-28 | 2020-10-02 | 中国科学院宁波材料技术与工程研究所 | 一种复合醋酸纤维素正渗透膜及其制备方法与应用 |
US10729822B2 (en) | 2017-12-01 | 2020-08-04 | The Regents Of The University Of California | Biofouling resistant coatings and methods of making and using the same |
CN108043237A (zh) * | 2017-12-21 | 2018-05-18 | 天津工业大学 | 一种pda-pam接枝改性的亲水性反渗透膜及其制备方法 |
US20210040257A1 (en) * | 2018-03-16 | 2021-02-11 | Zymergen Inc. | Surface formulations comprising phenols |
KR102143837B1 (ko) * | 2018-03-27 | 2020-08-12 | 고려대학교 산학협력단 | 방오 활성을 가지는 효소기반 수처리용 멤브레인 및 이의 제조방법 |
KR102143838B1 (ko) * | 2018-03-27 | 2020-08-12 | 고려대학교 산학협력단 | 표면 항균 활성을 갖는 효소기반 수처리용 멤브레인 및 이의 제조방법 |
CN110354536A (zh) * | 2018-04-09 | 2019-10-22 | 天津工业大学 | 一种超亲水/水下超疏油的油水分离金属网膜制备方法 |
CN108579450A (zh) * | 2018-05-15 | 2018-09-28 | 四川大学 | 一种耐溶剂水包油型乳液分离膜及其制备方法 |
CN108654408A (zh) * | 2018-05-16 | 2018-10-16 | 东华大学 | 一种pda改性热压纳米纤维正渗透膜及其制备方法 |
US10864481B1 (en) | 2018-08-20 | 2020-12-15 | Dileep Kumar Agnihotri | Energy efficient low-fouling high-recovery reverse osmosis system for brackish water desalination |
CN109012186A (zh) * | 2018-08-24 | 2018-12-18 | 天津碧水源膜材料有限公司 | 抗污染改性反渗透膜及其制备方法 |
CN109052543B (zh) * | 2018-09-11 | 2021-12-17 | 燕山大学 | 一种回收废水中贵金属银的方法 |
CN109482071B (zh) * | 2018-11-16 | 2021-06-22 | 江苏大学 | 一种PVDF/GO@PDA@HNTs复合膜的制备方法及其用途 |
CN109647219B (zh) * | 2019-01-30 | 2021-10-26 | 自然资源部天津海水淡化与综合利用研究所 | 一种聚偏氟乙烯抗污染抑菌膜及其制备方法 |
CN109876673A (zh) * | 2019-03-04 | 2019-06-14 | 嘉兴南洋职业技术学院 | 以多巴胺为二级平台构建超浸润高分子膜的方法及其应用 |
CN110075724B (zh) * | 2019-04-04 | 2021-08-06 | 镇江恒昌彩艺科技有限公司 | 一种水下超疏油pvdf@pvp复合膜的制备方法及其应用 |
KR20220054250A (ko) | 2019-06-05 | 2022-05-02 | 더 리전트 오브 더 유니버시티 오브 캘리포니아 | 생물오손-저항성 코팅 및 이의 제조 및 사용 방법 |
CN110302420A (zh) * | 2019-06-27 | 2019-10-08 | 福建工程学院 | 一种原位聚合pda涂覆表面修饰生物支架的制备方法 |
CN110280143B (zh) * | 2019-06-27 | 2022-04-19 | 三达膜科技(厦门)有限公司 | 一种多巴胺/氧化石墨烯/聚乙烯醇复合纳滤膜的制备方法 |
US11278847B2 (en) * | 2019-07-30 | 2022-03-22 | NL Chemical Technology, Inc | Reverse osmosis membrane with hydrogel coating |
CN112294695B (zh) * | 2019-08-02 | 2022-08-05 | 万华化学集团股份有限公司 | 一种基于聚多巴胺包裹水性聚氨酯分散体的水性指甲油 |
KR102217853B1 (ko) | 2019-08-09 | 2021-02-19 | 한국과학기술연구원 | 금속-유기 골격체와 셀룰로오스 나노섬유 복합체를 포함하는 수처리용 분리막 및 이의 제조방법 |
JP7226569B2 (ja) * | 2019-09-13 | 2023-02-21 | 東洋紡株式会社 | 複合膜および複合膜の製造方法 |
US11325077B2 (en) * | 2019-10-24 | 2022-05-10 | King Fahd University Of Petroleum And Minerals | Composite membrane containing a polydopamine-poly acyl halide matrix incorporating carbide-derived carbon and methods thereof |
KR102165492B1 (ko) * | 2019-12-24 | 2020-10-14 | 한국화학연구원 | 제거 성능이 향상된 내용매성 분리막 및 이의 제조방법 |
EP3862069A1 (en) * | 2020-02-06 | 2021-08-11 | Centre National de la Recherche Scientifique | Reverse electro-osmotic filtration system and uses thereof |
KR102300565B1 (ko) * | 2020-02-27 | 2021-09-13 | 영남대학교 산학협력단 | 인돌계 유기 화합물이 캡핑된 복합 나노 입자를 포함하는 기능성 고분자 분리막 및 이의 제조 방법 |
JP7424873B2 (ja) * | 2020-03-12 | 2024-01-30 | テルモ株式会社 | 人工肺およびその製造方法 |
CN111569680B (zh) * | 2020-06-02 | 2021-03-19 | 四川大学 | 聚芳醚超滤膜、纳滤膜及制备和超、纳滤可逆转换的方法 |
CN112516817B (zh) * | 2020-11-03 | 2022-10-11 | 贵州省材料产业技术研究院 | 一种聚偏氟乙烯疏松纳滤膜及其制备方法和应用 |
CN114618317B (zh) * | 2020-12-10 | 2024-03-19 | 财团法人纺织产业综合研究所 | 抗结垢过滤膜及其制备方法 |
CN113559720B (zh) * | 2021-07-12 | 2022-08-05 | 武汉理工大学 | 拥有仿肝素改性涂层的聚醚砜血液透析膜及其制备方法、应用 |
CN113697998A (zh) * | 2021-09-03 | 2021-11-26 | 自然资源部天津海水淡化与综合利用研究所 | 一种骨明胶浸灰废水处理方法 |
CN114177786B (zh) * | 2021-11-01 | 2022-12-30 | 深圳市惠康水务集团有限公司 | 一种多层聚酰胺复合反渗透膜的制备方法 |
CN114225719B (zh) * | 2021-12-17 | 2024-01-23 | 天津工业大学 | 纳米氧化铝改性热拉伸聚烯烃膜及其制备方法 |
WO2023131946A1 (en) * | 2022-01-05 | 2023-07-13 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Polymer-coated metal-containing- or carbon-based- article and method for the preparation thereof |
CN115178097B (zh) * | 2022-08-15 | 2024-02-23 | 无锡零界净化设备股份有限公司 | 一种pvdf微孔滤膜及其制备工艺 |
CN115487686B (zh) * | 2022-09-01 | 2023-08-29 | 成都博睿兴材科技有限公司 | 一种多功能电纺纤维复合膜及其制备方法与应用 |
Citations (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4066512A (en) * | 1974-09-06 | 1978-01-03 | Millipore Corporation | Biologically active membrane material |
US4220535A (en) * | 1978-08-04 | 1980-09-02 | Monsanto Company | Multi-zoned hollow fiber permeator |
US4564488A (en) * | 1978-07-31 | 1986-01-14 | Akzo Nv | Methods for the preparation of porous fibers and membranes |
US4636229A (en) * | 1984-03-26 | 1987-01-13 | Nippon Oil Company, Limited | Selective gas separation membrane |
US4767645A (en) * | 1986-04-21 | 1988-08-30 | Aligena Ag | Composite membranes useful for the separation of organic compounds of low molecular weight from aqueous inorganic salts containing solutions |
US4872982A (en) * | 1988-09-06 | 1989-10-10 | Separation Dynamics, Inc. | Composite semipermeable membranes and method of making same |
US5019261A (en) * | 1986-08-27 | 1991-05-28 | Dow Danmark A/S | Permeable, porous polymeric membrane with hydrophilic character methods for preparing said membranes and their use |
US5273657A (en) * | 1989-04-18 | 1993-12-28 | Daicel Chemical Industries, Ltd. | Process for preparing modified porous membrane |
US5846428A (en) * | 1994-11-23 | 1998-12-08 | Eastman Kodak Company | Method for modifying the surface of a polymer membrane, and a membrane thus modified |
US5954959A (en) * | 1997-05-09 | 1999-09-21 | Battelle Memorial Institute | Microdialysis unit for molecular weight separation |
US6177011B1 (en) * | 1996-03-18 | 2001-01-23 | Nitto Denko Corporation | Composite reverse osmosis membrane having a separation layer with polyvinyl alcohol coating and method of reverse osmotic treatment of water using the same |
US20030087338A1 (en) * | 2001-07-20 | 2003-05-08 | Messersmith Phillip B. | Adhesive DOPA-containing polymers and related methods of use |
US20040161447A1 (en) * | 2000-02-17 | 2004-08-19 | Leonard Paul | Liquid foam producing compositions and dispensing system therefor |
US20050164169A1 (en) * | 2004-01-27 | 2005-07-28 | Henryk Malak | Method of plasmon-enhanced properties of materials and applications thereof |
US20050287112A1 (en) * | 2004-06-21 | 2005-12-29 | Samsung Electronics Co., Ltd. | Antibacterial paint containing nano silver particles and coating method using the same |
US7094349B2 (en) * | 2002-08-08 | 2006-08-22 | Organo Corporation | Organic porous article having selective adsorption ability for boron, and boron removing module and ultra-pure water production apparatus using the same |
US20070175821A1 (en) * | 2006-02-01 | 2007-08-02 | Koo Ja-Young | Selective membrane having a high fouling resistance |
US20080149566A1 (en) * | 2006-10-19 | 2008-06-26 | Northwestern University | Surface-Independent, Surface-Modifying, Multifunctional Coatings and Applications Thereof |
US7537697B2 (en) * | 2006-02-01 | 2009-05-26 | Woongjin Chemical Co., Ltd. | Selective membrane having a high fouling resistance |
US7644825B2 (en) * | 2002-11-30 | 2010-01-12 | Gambro Lundia Ab | Membrane and use thereof |
US7858679B2 (en) * | 2001-07-20 | 2010-12-28 | Northwestern University | Polymeric compositions and related methods of use |
US8017050B2 (en) * | 2008-07-10 | 2011-09-13 | Board Of Regents The University Of Texas System | Water purification membranes with improved fouling resistance |
US20120111791A1 (en) * | 2010-11-04 | 2012-05-10 | Board Of Regents, The University Of Texas System | Surface Deposition of Small Molecules to Increase Water Purification Membrane Fouling Resistance |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS58128108A (ja) * | 1982-01-22 | 1983-07-30 | Toyobo Co Ltd | 酢酸セルロ−ス系逆浸透膜用処理剤 |
GB9523854D0 (en) * | 1995-11-22 | 1996-01-24 | Bratton Graham J | Water removal device |
US6280853B1 (en) | 1999-06-10 | 2001-08-28 | The Dow Chemical Company | Composite membrane with polyalkylene oxide modified polyamide surface |
JP2005044611A (ja) * | 2003-07-28 | 2005-02-17 | Toyobo Co Ltd | 複合イオン交換膜およびそれを用いた固体高分子型燃料電池 |
-
2009
- 2009-07-09 US US12/500,364 patent/US20100059433A1/en not_active Abandoned
- 2009-07-09 CN CN2009801353652A patent/CN102149450A/zh active Pending
- 2009-07-09 JP JP2011517629A patent/JP5463355B2/ja active Active
- 2009-07-09 AU AU2009268532A patent/AU2009268532B2/en not_active Ceased
- 2009-07-09 EP EP09795208.9A patent/EP2318126B1/en active Active
- 2009-07-09 US US12/500,514 patent/US8017050B2/en active Active
- 2009-07-09 BR BRPI0915547A patent/BRPI0915547A2/pt not_active Application Discontinuation
- 2009-07-09 WO PCT/US2009/050150 patent/WO2010006196A2/en active Application Filing
- 2009-07-09 CA CA2767761A patent/CA2767761C/en active Active
- 2009-07-09 MX MX2011000218A patent/MX2011000218A/es active IP Right Grant
- 2009-07-09 KR KR1020117003206A patent/KR101310054B1/ko active IP Right Grant
-
2011
- 2011-01-06 IL IL210488A patent/IL210488A/en not_active IP Right Cessation
- 2011-02-09 ZA ZA2011/01059A patent/ZA201101059B/en unknown
Patent Citations (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4066512A (en) * | 1974-09-06 | 1978-01-03 | Millipore Corporation | Biologically active membrane material |
US4564488A (en) * | 1978-07-31 | 1986-01-14 | Akzo Nv | Methods for the preparation of porous fibers and membranes |
US4220535A (en) * | 1978-08-04 | 1980-09-02 | Monsanto Company | Multi-zoned hollow fiber permeator |
US4636229A (en) * | 1984-03-26 | 1987-01-13 | Nippon Oil Company, Limited | Selective gas separation membrane |
US4767645A (en) * | 1986-04-21 | 1988-08-30 | Aligena Ag | Composite membranes useful for the separation of organic compounds of low molecular weight from aqueous inorganic salts containing solutions |
US4833014A (en) * | 1986-04-21 | 1989-05-23 | Aligena Ag | Composite membranes useful for the separation of organic compounds of low molecular weight from aqueous inorganic salts containing solutions |
US5019261A (en) * | 1986-08-27 | 1991-05-28 | Dow Danmark A/S | Permeable, porous polymeric membrane with hydrophilic character methods for preparing said membranes and their use |
US5091086A (en) * | 1986-08-27 | 1992-02-25 | Danisco A/S | Permeable, porous polymeric membrane with hydrophilic character, methods for preparing said membranes and their use |
US4872982A (en) * | 1988-09-06 | 1989-10-10 | Separation Dynamics, Inc. | Composite semipermeable membranes and method of making same |
US5273657A (en) * | 1989-04-18 | 1993-12-28 | Daicel Chemical Industries, Ltd. | Process for preparing modified porous membrane |
US5846428A (en) * | 1994-11-23 | 1998-12-08 | Eastman Kodak Company | Method for modifying the surface of a polymer membrane, and a membrane thus modified |
US6177011B1 (en) * | 1996-03-18 | 2001-01-23 | Nitto Denko Corporation | Composite reverse osmosis membrane having a separation layer with polyvinyl alcohol coating and method of reverse osmotic treatment of water using the same |
US5954959A (en) * | 1997-05-09 | 1999-09-21 | Battelle Memorial Institute | Microdialysis unit for molecular weight separation |
US20040161447A1 (en) * | 2000-02-17 | 2004-08-19 | Leonard Paul | Liquid foam producing compositions and dispensing system therefor |
US20030087338A1 (en) * | 2001-07-20 | 2003-05-08 | Messersmith Phillip B. | Adhesive DOPA-containing polymers and related methods of use |
US7858679B2 (en) * | 2001-07-20 | 2010-12-28 | Northwestern University | Polymeric compositions and related methods of use |
US7094349B2 (en) * | 2002-08-08 | 2006-08-22 | Organo Corporation | Organic porous article having selective adsorption ability for boron, and boron removing module and ultra-pure water production apparatus using the same |
US7644825B2 (en) * | 2002-11-30 | 2010-01-12 | Gambro Lundia Ab | Membrane and use thereof |
US20050164169A1 (en) * | 2004-01-27 | 2005-07-28 | Henryk Malak | Method of plasmon-enhanced properties of materials and applications thereof |
US20050287112A1 (en) * | 2004-06-21 | 2005-12-29 | Samsung Electronics Co., Ltd. | Antibacterial paint containing nano silver particles and coating method using the same |
US7537697B2 (en) * | 2006-02-01 | 2009-05-26 | Woongjin Chemical Co., Ltd. | Selective membrane having a high fouling resistance |
US20070175821A1 (en) * | 2006-02-01 | 2007-08-02 | Koo Ja-Young | Selective membrane having a high fouling resistance |
US20080149566A1 (en) * | 2006-10-19 | 2008-06-26 | Northwestern University | Surface-Independent, Surface-Modifying, Multifunctional Coatings and Applications Thereof |
US8541060B2 (en) * | 2006-10-19 | 2013-09-24 | Northwestern University | Surface-independent, surface-modifying, multifunctional coatings and application thereof |
US8017050B2 (en) * | 2008-07-10 | 2011-09-13 | Board Of Regents The University Of Texas System | Water purification membranes with improved fouling resistance |
US20120111791A1 (en) * | 2010-11-04 | 2012-05-10 | Board Of Regents, The University Of Texas System | Surface Deposition of Small Molecules to Increase Water Purification Membrane Fouling Resistance |
Non-Patent Citations (1)
Title |
---|
Thermo Scientific, Technical Supplement: Microparticle Reagent Optimization - Microparticle Sonication and Mixing, Sep. 2007. * |
Cited By (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11452291B2 (en) | 2007-05-14 | 2022-09-27 | The Research Foundation for the State University | Induction of a physiological dispersion response in bacterial cells in a biofilm |
WO2012009720A1 (en) * | 2010-07-16 | 2012-01-19 | University Of Connecticut | Method of modifying thin film composite membrane support structures for engineered osmosis applications |
KR20140040065A (ko) * | 2010-09-30 | 2014-04-02 | 포리페라 인코포레이티드 | 정삼투용 박막 복합 멤브레인 및 이의 제조 방법 |
US20120080378A1 (en) * | 2010-09-30 | 2012-04-05 | Ravindra Revanur | Thin film composite membranes for forward osmosis, and their preparation methods |
KR101892108B1 (ko) | 2010-09-30 | 2018-08-27 | 포리페라 인코포레이티드 | 정삼투용 박막 복합 멤브레인 및 이의 제조 방법 |
US8920654B2 (en) * | 2010-09-30 | 2014-12-30 | Porifera, Inc. | Thin film composite membranes for forward osmosis, and their preparation methods |
US9216391B2 (en) | 2011-03-25 | 2015-12-22 | Porifera, Inc. | Membranes having aligned 1-D nanoparticles in a matrix layer for improved fluid separation |
WO2012158717A3 (en) * | 2011-05-16 | 2013-03-28 | Advanced Hydro Inc | Improved membranes with polydopamine coatings |
US10518226B2 (en) | 2011-05-16 | 2019-12-31 | Dileep Agnihotri | Membranes with polydopamine coatings |
WO2012158717A2 (en) * | 2011-05-16 | 2012-11-22 | Advanced Hydro Inc | Improved membranes with polydopamine coatings |
US9221019B2 (en) | 2011-05-27 | 2015-12-29 | Samsung Electronics Co., Ltd. | Organic/inorganic hybrid compound for fouling resistance, membrane including the same for fouling resistance, and method of preparing membrane for fouling resistance |
US8999043B2 (en) * | 2011-08-02 | 2015-04-07 | Denso Corporation | Air conditioning system |
CN103717978A (zh) * | 2011-08-02 | 2014-04-09 | 株式会社电装 | 空调系统 |
US20140165838A1 (en) * | 2011-08-02 | 2014-06-19 | Denso Corporation | Air conditioning system |
US9227360B2 (en) | 2011-10-17 | 2016-01-05 | Porifera, Inc. | Preparation of aligned nanotube membranes for water and gas separation applications |
KR101327891B1 (ko) | 2012-02-02 | 2013-11-11 | 에스케이씨 주식회사 | 생체고분자로 코팅된 다공성 필름 및 이를 포함하는 이차전지용 분리막 |
US10239021B2 (en) | 2012-06-14 | 2019-03-26 | Teledyne Scientific & Imaging, Llc | Fouling resistant coating for filtration membranes and methods of producing and using same |
US20150176852A1 (en) * | 2012-11-30 | 2015-06-25 | C'stec Corporation | Wall, system of highly clean rooms, production method thereof and construction |
US10677483B2 (en) * | 2012-11-30 | 2020-06-09 | C'stec Corporation | Wall, system of highly clean rooms, production method thereof and construction |
US11402108B2 (en) | 2012-11-30 | 2022-08-02 | Akira Ishibashi | Wall, system of highly clean rooms, production method thereof and construction |
US10464023B2 (en) | 2012-12-21 | 2019-11-05 | Porifera, Inc. | Separation systems, elements, and methods for separation utilizing stacked membranes and spacers |
US11090611B2 (en) | 2012-12-21 | 2021-08-17 | Porifera, Inc. | Separation systems, elements, and methods for separation utilizing stacked membranes and spacers |
US9636635B2 (en) | 2012-12-21 | 2017-05-02 | Porifera, Inc. | Separation systems, elements, and methods for separation utilizing stacked membranes and spacers |
US11759751B2 (en) | 2012-12-21 | 2023-09-19 | Porifera, Inc. | Separation systems, elements, and methods for separation utilizing stacked membranes and spacers |
US9861937B2 (en) | 2013-03-15 | 2018-01-09 | Porifera, Inc. | Advancements in osmotically driven membrane systems including low pressure control |
US10500544B2 (en) | 2013-03-15 | 2019-12-10 | Porifera, Inc. | Advancements in osmotically driven membrane systems including multi-stage purification |
CN103394295A (zh) * | 2013-08-14 | 2013-11-20 | 哈尔滨工业大学 | 一种亲水性pvdf复合超滤膜及其制备方法 |
US10220355B2 (en) | 2013-12-09 | 2019-03-05 | Samsung Electronics Co., Ltd. | Compound for fouling resistance, membrane for fouling resistance, and method of preparing membrane for fouling resistance |
US20150375181A1 (en) * | 2014-06-30 | 2015-12-31 | Pall Corporation | Fluorinated polymer and use thereof in the preparation of hydrophilic membranes (vi) |
US9962662B2 (en) * | 2014-06-30 | 2018-05-08 | Pall Corporation | Fluorinated polymer and use thereof in the preparation of hydrophilic membranes (vi) |
US10384169B2 (en) | 2014-10-31 | 2019-08-20 | Porifera, Inc. | Supported carbon nanotube membranes and their preparation methods |
US10322360B2 (en) | 2015-05-01 | 2019-06-18 | Teledyne Scientific & Imaging, Llc | Coated granular filtration media |
WO2016178935A1 (en) | 2015-05-01 | 2016-11-10 | Teledyne Scientific & Imaging, Llc | Coated granular filtration media |
US11571660B2 (en) | 2015-06-24 | 2023-02-07 | Porifera, Inc. | Methods of dewatering of alcoholic solutions via forward osmosis and related systems |
US11389386B2 (en) | 2016-01-29 | 2022-07-19 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Photochemically stable, non-leaching, bridged polysilsesquioxane based sunscreens |
WO2018013587A1 (en) * | 2016-07-11 | 2018-01-18 | The Arizona Board Of Regents On Behalf Of The University Of Arizona | Polymeric sunscreen materials |
WO2018044675A1 (en) * | 2016-08-29 | 2018-03-08 | The Penn State Research Foundation | Membrane surface activation to eliminate fouling and concentration polarization in water purification systems |
US10874994B2 (en) | 2016-08-29 | 2020-12-29 | The Penn State Research Foundation | Membrane surface activation to eliminate fouling and concentration polarization in water purification systems |
US11541352B2 (en) | 2016-12-23 | 2023-01-03 | Porifera, Inc. | Removing components of alcoholic solutions via forward osmosis and related systems |
JP2018173306A (ja) * | 2017-03-31 | 2018-11-08 | 日立化成株式会社 | 分離材及びカラム |
KR20190042302A (ko) | 2017-10-16 | 2019-04-24 | 한국과학기술연구원 | 질화 붕소 나노 물질을 이용한 가열 재생 가능한 한외여과막과 그 제조 및 재생 방법 |
US11541105B2 (en) | 2018-06-01 | 2023-01-03 | The Research Foundation For The State University Of New York | Compositions and methods for disrupting biofilm formation and maintenance |
US20210054172A1 (en) * | 2019-08-20 | 2021-02-25 | B. J. Zh. F. Panther Medical Equipment Co., Ltd. | Polydopamine film and preparation method and application thereof |
US12005396B2 (en) | 2019-11-14 | 2024-06-11 | Porifera, Inc. | Advancements in osmotically driven membrane systems including multi-stage purification |
WO2021222266A1 (en) * | 2020-04-27 | 2021-11-04 | The Trustees Of Princeton University | Solar-powered water purification and decontamination gel compositions |
CN112778564A (zh) * | 2021-01-06 | 2021-05-11 | 吉林大学 | 碳纤维增强聚醚醚酮复合材料及生物活性改善方法和应用 |
EP4201508A1 (en) | 2021-12-21 | 2023-06-28 | Gambro Lundia AB | Membrane coated with polydopamine and chondroitin and process for producing same |
EP4201507A1 (en) | 2021-12-21 | 2023-06-28 | Gambro Lundia AB | Method for increasing the selectivity of a membrane |
WO2023117812A1 (en) | 2021-12-21 | 2023-06-29 | Gambro Lundia Ab | Membrane coated with polydopamine and chondroitin and process for producing same |
WO2023117808A1 (en) | 2021-12-21 | 2023-06-29 | Gambro Lundia Ab | Method for increasing the selectivity of a membrane |
Also Published As
Publication number | Publication date |
---|---|
JP2011527632A (ja) | 2011-11-04 |
KR20110042307A (ko) | 2011-04-26 |
CA2767761A1 (en) | 2010-01-14 |
AU2009268532B2 (en) | 2013-01-10 |
WO2010006196A8 (en) | 2010-08-12 |
CA2767761C (en) | 2016-03-08 |
IL210488A (en) | 2016-08-31 |
US20100051538A1 (en) | 2010-03-04 |
WO2010006196A2 (en) | 2010-01-14 |
EP2318126B1 (en) | 2018-08-22 |
EP2318126A4 (en) | 2015-09-16 |
MX2011000218A (es) | 2011-07-29 |
ZA201101059B (en) | 2011-10-26 |
US8017050B2 (en) | 2011-09-13 |
AU2009268532A1 (en) | 2010-01-14 |
IL210488A0 (en) | 2011-03-31 |
EP2318126A2 (en) | 2011-05-11 |
BRPI0915547A2 (pt) | 2016-01-26 |
WO2010006196A3 (en) | 2010-04-15 |
CN102149450A (zh) | 2011-08-10 |
KR101310054B1 (ko) | 2013-09-24 |
JP5463355B2 (ja) | 2014-04-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20100059433A1 (en) | Polymer deposition and modification of membranes for fouling resistance | |
WO2011005258A1 (en) | Polymer deposition and modification of membranes for fouling resistance | |
Miller et al. | Surface modification of water purification membranes | |
Karkhanechi et al. | Biofouling resistance of reverse osmosis membrane modified with polydopamine | |
Ba et al. | Using polyelectrolyte coatings to improve fouling resistance of a positively charged nanofiltration membrane | |
Lau et al. | Recent progress of zwitterionic materials as antifouling membranes for ultrafiltration, nanofiltration, and reverse osmosis | |
US7490725B2 (en) | Reverse osmosis membrane and process | |
Shahkaramipour et al. | Facile grafting of zwitterions onto the membrane surface to enhance antifouling properties for wastewater reuse | |
US20120111791A1 (en) | Surface Deposition of Small Molecules to Increase Water Purification Membrane Fouling Resistance | |
WO2011008549A2 (en) | Improved hybrid tfc ro membranes with nitrogen additives | |
Xu et al. | Enhancing the chlorine stability and antifouling properties of thin-film composite reverse osmosis membranes via surface grafting L-arginine-functionalized polyvinyl alcohol | |
CA2981401A1 (en) | Processes for reducing the fouling of surfaces | |
Wang et al. | Construction of a stable zwitterionic layer on negatively-charged membrane via surface adsorption and cross-linking | |
CN108786498B (zh) | 一种表面改性制备抗粘附抗生物污染反渗透膜及制备方法 | |
Xia et al. | Poly (ether sulfone) membrane surface modification using norepinephrine to mitigate fouling | |
Cheng et al. | Surface modification of ultrafiltration membranes with 1, 4-benzoquinone and polyetheramines to improve fouling resistance | |
Le et al. | Zwitterionic triamine monomer for the fabrication of thin-film composite membranes | |
McCloskey | Novel surface modifications and materials for fouling resistant water purification membranes | |
WO2014095717A1 (en) | Mixed matrix membranes comprising vanadium pentoxide nanoparticles and methods for their preparation | |
de Grooth | A tale of two charges: zwitterionic polyelectrolyte multilayer membranes | |
KR102153314B1 (ko) | 생물오손 방지용 역삼투막 및 이를 이용하는 장치 | |
Ilyas | Multifunctional weak polyelectrolyte multilayers for membrane applications | |
Koo et al. | Fouling resistant reverse osmosis membranes | |
KR100477584B1 (ko) | 역삼투분리막의후처리공정 | |
CN118076563A (zh) | 两亲性聚两性电解质及相关膜 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM,T Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:FREEMAN, BENNY D.;PARK, HO BUM;MCCLOSKEY, BRYAN D.;AND OTHERS;SIGNING DATES FROM 20091103 TO 20091106;REEL/FRAME:023667/0382 |
|
AS | Assignment |
Owner name: NATIONAL SCIENCE FOUNDATION, VIRGINIA Free format text: CONFIRMATORY LICENSE;ASSIGNOR:THE UNIVERSITY OF TEXAS AT AUSTIN;REEL/FRAME:025568/0620 Effective date: 20101105 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |